Amedisys, Inc(NASDAQ:AMED) 
Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and Personal Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, ch...
Website: http://www.amedisys.com
Founded: 1982
Full Time Employees: 21,000
Sector: Healthcare
Industry: Medical Care Facilities
• Market Cap:
• Exchange:
• Shs Outstanding:
• Employees:
• Beta:
• Return on Equity (ROE) ttm:
• Return on Assets (ROA) ttm:
• EPS ttm:
• Book value per Share:
• Cash per Share:
• Current ast per Share:
• P/E ttm:
• P/E forward:
• P/E ttm high:
• P/E ttm low:
• P/S ttm:
• P/B ttm:
• P/FCF ttm:
• PEG ratio:
• Cash Ratio ttm:
• Quick Ratio ttm:
• Current Ratio ttm:
• Gross Mgn ttm:
• EBITDA Mgn ttm:
• Operating Mgn ttm:
• Net Income Mgn ttm:
• Trailing Div yield:
• Forward Div yield:
• Payout Ratio ttm:
• Ex-Dividend date:
• Target Price High:
• Target Price Low:
• Target Price Mean:
• Number of Analysts:
• Debt Ratio ttm:
• Debt to Equity ttm:
• Total Net Debt:
At a glance:
Bull Thesis:
Bear Thesis:
Main Competitors:
Moat:
Income Statements:
Quarterly
Annual
| Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-12-31 | 2014-09-30 | 2014-06-30 | 2014-03-31 | 2013-12-31 | 2013-09-30 | 2013-06-30 | 2013-03-31 | 2012-12-31 | 2012-09-30 | 2012-06-30 | 2012-03-31 | 2011-12-31 | 2011-09-30 | 2011-06-30 | 2011-03-31 | 2010-12-31 | 2010-09-30 | 2010-06-30 | 2010-03-31 | 2009-12-31 | 2009-09-30 | 2009-06-30 | 2009-03-31 | 2008-12-31 | 2008-09-30 | 2008-06-30 | 2008-03-31 | 2007-12-31 | 2007-09-30 | 2007-06-30 | 2007-03-31 | 2006-12-31 | 2006-09-30 | 2006-06-30 | 2006-03-31 | 2005-12-31 | 2005-09-30 | 2005-06-30 | 2005-03-31 | 2004-12-31 | 2004-09-30 | 2004-06-30 | 2004-03-31 | 2003-12-31 | 2003-09-30 | 2003-06-30 | 2003-03-31 | 2002-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
net service revenue | 621,861,000 | 594,781,000 | 1,760,653,000 | 587,671,000 | 591,187,000 | 571,414,000 | 1,680,145,000 | 556,237,000 | 552,968,000 | 556,389,000 | 1,665,211,000 | 557,988,000 | 557,890,000 | 545,257,000 | 1,660,627,000 | 553,485,000 | 564,166,000 | 537,144,000 | 1,527,449,000 | 544,070,000 | 485,059,000 | 491,685,000 | 1,461,002,000 | 494,631,000 | 492,984,000 | 467,340,000 | 417,335,000 | 411,603,000 | 399,262,000 | 380,163,000 | 378,821,000 | 370,458,000 | 361,595,000 | 360,746,000 | 348,817,000 | 326,450,000 | 314,152,000 | 301,572,000 | 300,281,000 | 305,006,000 | 298,739,000 | 301,639,000 | 313,148,000 | 339,175,000 | 375,625,000 | 378,498,000 | 370,833,000 | 374,861,000 | 373,722,000 | 364,302,000 | 404,680,000 | 422,349,000 | 412,967,000 | 388,257,000 | 377,892,000 | 341,838,000 | 321,561,000 | 312,671,000 | 213,087,000 | 180,910,000 | 169,457,000 | 153,581,000 | 137,041,000 | 132,910,000 | 127,187,000 | 118,893,000 | 112,166,000 | 80,061,000 | 70,437,000 | 64,360,000 | 58,494,000 | 56,896,000 | 47,339 | 42,099 | 37,048 | 32,194 | 31,132 | ||||||||||||||
operating expenses: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cost of service, inclusive of depreciation | 348,470,000 | 334,050,000 | 993,084,000 | 337,563,000 | 326,933,000 | 321,537,000 | 933,881,000 | 311,628,000 | 297,455,000 | 315,010,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
general and administrative expenses: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
salaries and benefits | 130,322,000 | 131,968,000 | 394,915,000 | 134,833,000 | 129,323,000 | 127,946,000 | 386,966,000 | 129,083,000 | 125,504,000 | 126,339,000 | 383,241,000 | 125,550,000 | 127,758,000 | 123,480,000 | 355,345,000 | 119,373,000 | 114,335,000 | 115,825,000 | 326,302,000 | 123,146,000 | 105,617,000 | 101,566,000 | 294,511,000 | 99,941,000 | 98,356,000 | 94,830,000 | 79,367,000 | 77,215,000 | 75,631,000 | 77,130,000 | 74,943,000 | 74,459,000 | 77,019,000 | 77,343,000 | 76,717,000 | 69,993,000 | 71,249,000 | 68,555,000 | 69,461,000 | 71,400,000 | 83,171,000 | 73,993,000 | 74,601,000 | 82,794,000 | 81,627,000 | 86,499,000 | 87,077,000 | 87,106,000 | 80,862,000 | 85,650,000 | 90,354,000 | 89,210,000 | 87,499,000 | 87,260,000 | 82,055,000 | 73,025,000 | 72,124,000 | 72,751,000 | 45,948,000 | 43,238,000 | 43,194,000 | 37,277,000 | 32,389,000 | 34,025,000 | 32,145,000 | 28,824,000 | 27,798,000 | 18,857,000 | 18,005,000 | 15,348,000 | 14,217,000 | 14,794,000 | 12,557 | 11,048 | 10,462 | 9,881 | 9,861 | ||||||||||||||
non-cash compensation | 7,266,000 | 6,223,000 | 22,302,000 | 6,726,000 | 7,828,000 | 7,433,000 | 19,470,000 | 6,612,000 | 9,108,000 | 3,273,000 | 13,065,000 | 3,495,000 | 5,148,000 | 7,347,000 | 19,412,000 | 4,397,000 | 6,156,000 | 7,307,000 | 19,606,000 | 7,124,000 | 6,725,000 | 5,909,000 | 18,742,000 | 6,298,000 | 5,538,000 | 6,615,000 | 4,842,000 | 3,767,000 | 4,044,000 | 3,558,000 | 4,356,000 | 3,874,000 | 4,750,000 | 3,736,000 | 4,070,000 | 3,060,000 | 2,193,000 | 2,384,000 | 1,697,000 | 1,069,000 | 431,000 | 1,653,000 | 1,224,000 | 2,056,000 | 1,285,000 | 2,298,000 | 2,482,000 | 3,150,000 | 3,205,000 | 1,910,000 | 2,636,000 | 3,168,000 | 2,513,000 | 820,000 | 2,779,000 | 2,141,000 | 1,923,000 | 1,268,000 | 1,053,000 | 828,000 | 800,000 | 731,000 | 797,000 | 597,000 | 596,000 | ||||||||||||||||||||||||||
merger-related expenses | 26,277,000 | 16,769,000 | 49,969,000 | 16,669,000 | 11,901,000 | 20,667,000 | 31,692,000 | 4,980,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
depreciation and amortization | 4,372,000 | 4,447,000 | 13,223,000 | 4,774,000 | 4,386,000 | 4,271,000 | 13,311,000 | 4,436,000 | 4,725,000 | 4,443,000 | 19,458,000 | 5,477,000 | 6,220,000 | 8,008,000 | 23,414,000 | 7,487,000 | 6,721,000 | 7,555,000 | 20,519,000 | 8,283,000 | 6,334,000 | 5,338,000 | 14,062,000 | 4,366,000 | 5,179,000 | 2,895,000 | 3,164,000 | 3,125,000 | 3,593,000 | 4,185,000 | 4,537,000 | 4,417,000 | 5,214,000 | 4,975,000 | 4,473,000 | 4,646,000 | 4,615,000 | 6,537,000 | 6,515,000 | 7,692,000 | 7,902,000 | 10,471,000 | 11,674,000 | 10,123,000 | 9,963,000 | 9,905,000 | 10,054,000 | 9,826,000 | 9,726,000 | 9,355,000 | 8,832,000 | 8,279,000 | 8,186,000 | 7,481,000 | 6,919,000 | 6,282,000 | 5,885,000 | 5,419,000 | 4,424,000 | 3,853,000 | 3,030,000 | 2,741,000 | 2,487,000 | 2,477,000 | 2,373,000 | ||||||||||||||||||||||||||
impairment | 883,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other | 58,693,000 | 57,965,000 | 174,560,000 | 56,777,000 | 58,602,000 | 57,941,000 | 180,642,000 | 57,287,000 | 78,381,000 | 64,945,000 | 169,408,000 | 59,299,000 | 54,912,000 | 53,640,000 | 157,555,000 | 55,158,000 | 54,731,000 | 49,106,000 | 142,774,000 | 49,348,000 | 44,003,000 | 49,265,000 | 139,960,000 | 48,474,000 | 48,408,000 | 43,402,000 | 40,335,000 | 42,104,000 | 41,680,000 | 38,189,000 | 41,617,000 | 40,417,000 | 42,658,000 | 45,576,000 | 46,717,000 | 39,551,000 | 42,113,000 | 33,070,000 | 32,018,000 | 35,522,000 | 42,698,000 | 40,360,000 | 41,121,000 | 43,562,000 | 48,261,000 | 47,286,000 | 44,394,000 | 47,697,000 | 46,644,000 | 45,565,000 | 54,177,000 | 51,799,000 | 44,648,000 | 43,765,000 | 42,425,000 | 42,266,000 | 40,641,000 | 45,726,000 | 33,056,000 | 27,955,000 | 23,735,000 | 25,106,000 | 23,326,000 | 23,458,000 | 23,583,000 | 25,713,000 | 21,328,000 | 15,439,000 | 12,459,000 | 11,730,000 | 10,184,000 | 10,406,000 | 8,397 | 7,999 | 7,495 | 6,657 | 6,178 | ||||||||||||||
total operating expenses | 576,283,000 | 551,422,000 | 1,696,444,000 | 557,342,000 | 538,973,000 | 539,795,000 | 1,565,962,000 | 514,026,000 | 515,173,000 | 514,010,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
operating income | 45,578,000 | 43,359,000 | 64,209,000 | 30,329,000 | 52,214,000 | 31,619,000 | 114,183,000 | 42,211,000 | 37,795,000 | 42,379,000 | 141,841,000 | 38,931,000 | 47,641,000 | 47,962,000 | 195,143,000 | 56,772,000 | 78,135,000 | 68,849,000 | 155,955,000 | 63,313,000 | 49,932,000 | 43,870,000 | 130,628,000 | 46,844,000 | 44,751,000 | 44,324,000 | 39,888,000 | 42,828,000 | 36,005,000 | 23,373,000 | 240,000 | 25,165,000 | 14,359,000 | 18,358,000 | 11,063,000 | 16,715,000 | 15,527,000 | -58,104,000 | 16,248,000 | 12,561,000 | -19,573,000 | -154,292,000 | 3,793,000 | 4,169,000 | 14,681,000 | 15,549,000 | 12,457,000 | -557,317,000 | 38,010,000 | 27,481,000 | 37,108,000 | 56,128,000 | 61,714,000 | 60,734,000 | 59,540,000 | 46,919,000 | 43,638,000 | 38,753,000 | 27,838,000 | 25,736,000 | 24,041,000 | 20,692,000 | 18,165,000 | 15,689,000 | 12,720,000 | 11,840,000 | 14,029,000 | 12,721,000 | 11,512,000 | 9,950,000 | 8,440,000 | 8,083,000 | 6,905 | 5,706 | 3,892 | 2,556 | 2,184 | ||||||||||||||
yoy | -12.71% | 37.13% | -43.77% | -28.15% | 38.15% | -25.39% | -19.50% | 8.43% | -20.67% | -11.64% | -27.31% | -31.43% | -39.03% | -30.34% | 25.13% | -10.33% | 56.48% | 56.94% | 19.39% | 35.16% | 11.58% | -1.02% | 17.44% | 4.49% | 23.11% | 70.66% | 17745.00% | 43.08% | 62.78% | -98.69% | 127.47% | -14.10% | 18.23% | -119.04% | 2.87% | 23.61% | 196.86% | -110.53% | 231.16% | -569.49% | -1150.96% | -75.61% | -66.53% | -102.63% | -59.09% | -54.67% | -1601.88% | -32.28% | -55.47% | -38.90% | -5.73% | 31.53% | 39.18% | 53.64% | 68.54% | 69.56% | 61.20% | 34.54% | 41.68% | 53.23% | 62.67% | 29.48% | 23.33% | 10.49% | 18.99% | 66.22% | 57.38% | 166619.77% | 174277.85% | 216755.09% | 316136.31% | 216.16% | |||||||||||||||||||
qoq | 5.12% | -32.47% | 111.71% | -41.91% | 65.13% | -72.31% | 170.51% | 11.68% | -10.82% | -70.12% | 264.34% | -18.28% | -0.67% | -75.42% | 243.73% | -27.34% | 13.49% | -55.85% | 146.32% | 26.80% | 13.82% | -66.42% | 178.86% | 4.68% | 0.96% | -6.86% | 18.95% | 9638.75% | -99.05% | -21.78% | 65.94% | 7.65% | -126.72% | 29.35% | -164.18% | -4167.81% | -9.02% | -5.58% | 24.82% | -1566.24% | 38.31% | -33.89% | -9.05% | 2.01% | 26.90% | 12.61% | 39.21% | 7.05% | 16.18% | 15.78% | 23.34% | 7.43% | -15.60% | 10.28% | 10.50% | 15.70% | 17.89% | 4.42% | 116960.10% | 21.01% | 46.61% | 52.27% | 17.03% | ||||||||||||||||||||||||||||
other income: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
interest income | 3,016,000 | 2,873,000 | 6,093,000 | 2,017,000 | 1,617,000 | 1,727,000 | 1,966,000 | 1,304,000 | 742,000 | 406,000 | 119,000 | 59,000 | 36,000 | 13,000 | 25,000 | 24,000 | 261,000 | 31,000 | 214,000 | 13,000 | 63,000 | 15,000 | 20,000 | 24,000 | 29,000 | 114,000 | 120,000 | 44,000 | 41,000 | 19,000 | 14,000 | 9,000 | 22,000 | 7,000 | 4,000 | 22,000 | 24,000 | 16,000 | 6,000 | 18,000 | 11,000 | 11,000 | 10,000 | 27,000 | 15,000 | 18,000 | 89,000 | 118,000 | 197,000 | 92,000 | 85,000 | 28,000 | 52,000 | 81,000 | 200,000 | 270,000 | 468,000 | 965,000 | 1,199,000 | 956,000 | 209,000 | 220,000 | 206,000 | 324,000 | 240,000 | 519,000 | 381,000 | 370,000 | 84,000 | 44,000 | 52 | 32 | 18 | 24 | 17 | ||||||||||||||||
interest expense | -6,415,000 | -6,422,000 | -22,992,000 | -7,772,000 | -7,895,000 | -8,119,000 | -23,253,000 | -8,021,000 | -7,502,000 | -7,517,000 | -17,265,000 | -4,963,000 | -8,311,000 | -3,173,000 | -6,795,000 | -2,730,000 | -1,932,000 | -2,072,000 | -8,346,000 | -2,692,000 | -2,752,000 | -3,231,000 | -10,737,000 | -3,778,000 | -4,332,000 | -3,349,000 | -1,991,000 | -2,140,000 | -1,703,000 | -1,335,000 | -1,197,000 | -1,068,000 | -1,136,000 | -1,303,000 | -1,112,000 | -4,936,000 | -2,416,000 | -2,426,000 | -2,990,000 | -1,352,000 | -1,261,000 | -687,000 | -730,000 | -1,106,000 | -1,982,000 | -2,002,000 | -2,074,000 | -2,187,000 | -2,254,000 | -2,252,000 | -2,277,000 | -2,350,000 | -2,411,000 | -2,682,000 | -2,958,000 | -3,455,000 | -5,033,000 | -5,448,000 | -1,126,000 | -209,000 | -174,000 | -93,000 | -873,000 | -1,122,000 | -1,124,000 | -1,108,000 | -1,537,000 | -142,000 | -145,000 | -144,000 | -142,000 | -100,000 | -124 | -296 | -296 | -341 | -360 | ||||||||||||||
equity in earnings from equity method investments | 1,641,000 | 1,794,000 | 4,376,000 | 1,891,000 | 1,515,000 | 910,000 | 9,508,000 | 1,252,000 | 7,991,000 | 123,000 | -347,000 | 302,000 | 659,000 | -1,403,000 | 3,505,000 | 1,444,000 | 1,370,000 | 1,118,000 | 2,531,000 | 1,435,000 | 487,000 | 477,000 | 6,150,000 | -812,000 | 3,716,000 | 1,216,000 | 1,625,000 | 2,976,000 | 1,860,000 | 900,000 | 2,355,000 | 3,244,000 | 363,000 | -5,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
gain on equity method investment | 48,093,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
miscellaneous | 4,506,000 | 1,508,000 | 5,543,000 | 2,522,000 | 1,779,000 | 1,090,000 | 5,272,000 | 1,201,000 | 4,743,000 | -682,000 | 1,076,000 | 491,000 | 331,000 | 333,000 | 1,255,000 | 490,000 | 475,000 | 288,000 | -1,791,000 | 122,000 | -2,703,000 | 263,000 | 62,000 | 1,975,000 | 193,000 | 236,000 | 1,822,000 | 359,000 | 601,000 | 1,043,000 | 1,127,000 | 1,112,000 | 1,713,000 | 658,000 | 735,000 | 1,330,000 | 498,000 | 2,134,000 | 110,000 | 243,000 | 190,000 | 5,102,000 | 136,000 | 59,000 | -14,000 | -134,000 | 429,000 | -176,000 | -425,000 | -339,000 | -65,000 | -1,575,000 | 201,000 | 979,000 | 943,000 | 778,000 | -186,000 | 148,000 | 29,000 | -64,000 | -802,000 | 155,000 | -247,000 | 5,000 | 100,000 | 60,000 | 74,000 | -12,000 | -15,000 | -31,000 | -21,000 | -3,000 | -4 | ||||||||||||||||||
total other income | 2,748,000 | 47,846,000 | -16,417,000 | -4,111,000 | -7,285,000 | 29,112,000 | -796,000 | 31,030,000 | -4,462,000 | -2,600,000 | -403,000 | -1,873,000 | 1,485,000 | 1,309,000 | 878,000 | 652,000 | 2,326,000 | 3,835,000 | -273,000 | -360,000 | -1,675,000 | 2,912,000 | 1,681,000 | -2,293,000 | 6,238,000 | -2,596,000 | -5,019,000 | -5,030,000 | -629,000 | 4,861,000 | 223,000 | 1,018,000 | -911,000 | -897,000 | -818,000 | 365,000 | 221,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
income before income taxes | 48,326,000 | 91,205,000 | 57,229,000 | 28,987,000 | 49,230,000 | 27,227,000 | 1,676,000 | 37,947,000 | -62,231,000 | 34,709,000 | 125,424,000 | 34,820,000 | 40,356,000 | 43,732,000 | 224,255,000 | 55,976,000 | 109,165,000 | 68,207,000 | 148,610,000 | 62,209,000 | 45,178,000 | 41,392,000 | 126,166,000 | 44,244,000 | 44,348,000 | 42,451,000 | 41,373,000 | 44,137,000 | 36,883,000 | 24,025,000 | 2,566,000 | 25,122,000 | 18,194,000 | 18,085,000 | 10,703,000 | 15,040,000 | 18,439,000 | -56,423,000 | 13,955,000 | 12,353,000 | -19,851,000 | -148,054,000 | 3,904,000 | 3,496,000 | 13,085,000 | 13,836,000 | 11,132,000 | -559,337,000 | 35,886,000 | 25,331,000 | 35,751,000 | 53,029,000 | 60,377,000 | 59,059,000 | 57,577,000 | 44,323,000 | 24,264,000 | 21,710,000 | 17,254,000 | 14,792,000 | 11,902,000 | 11,116,000 | 12,806,000 | 13,086,000 | 11,733,000 | 10,145,000 | 8,361,000 | 8,024,000 | 6,829 | 2,044 | 3,887 | 2,438 | 1,851 | ||||||||||||||||||
income tax expense | -19,274,000 | -29,384,000 | -35,581,000 | -12,473,000 | -16,657,000 | -12,633,000 | -38,228,000 | -12,331,000 | -18,250,000 | -9,800,000 | -33,128,000 | -9,417,000 | -11,319,000 | -12,019,000 | -28,546,000 | -17,915,000 | -10,031,000 | -9,346,000 | -32,584,000 | -9,919,000 | -10,308,000 | -10,878,000 | -9,825,000 | -9,563,000 | -9,364,000 | -9,923,000 | -1,566,000 | -1,363,000 | -5,742,000 | -4,620,000 | -14,175,000 | -10,007,000 | -13,943,000 | -20,663,000 | -23,547,000 | -23,033,000 | -22,455,000 | -17,286,000 | -15,144,000 | -13,337,000 | -10,772,000 | -10,391,000 | 9,347,000 | 8,445,000 | 6,695,000 | 5,739,000 | 4,618,000 | -33,462,000 | 5,045,000 | 5,156,000 | 4,623,000 | 2,211,500 | 3,175,000 | 3,063,000 | 2,608 | 783 | 1,506 | 924 | 702 | ||||||||||||||||||||||||||||||||
net income | 29,052,000 | 61,821,000 | 21,648,000 | 16,514,000 | 32,573,000 | 14,594,000 | -36,552,000 | 25,616,000 | -80,481,000 | 24,909,000 | 92,296,000 | 25,403,000 | 29,037,000 | 31,713,000 | 164,921,000 | 45,245,000 | 80,619,000 | 50,292,000 | 112,773,000 | 72,411,000 | 35,147,000 | 32,046,000 | 93,582,000 | 34,325,000 | 34,040,000 | 31,573,000 | 31,548,000 | 33,541,000 | 27,320,000 | 14,661,000 | 4,529,000 | 15,199,000 | 11,501,000 | 10,843,000 | 6,315,000 | 8,575,000 | 10,873,000 | -34,832,000 | 8,597,000 | 7,671,000 | -12,510,000 | -91,778,000 | 1,848,000 | 2,133,000 | 9,995,000 | 7,966,000 | 5,463,000 | -423,697,000 | 21,711,000 | 15,324,000 | 21,808,000 | 32,366,000 | 36,830,000 | 36,026,000 | 35,122,000 | 27,037,000 | 23,493,000 | 20,384,000 | 16,464,000 | 20,216,000 | 14,917,000 | 13,265,000 | 10,559,000 | 9,053,000 | 7,284,000 | 7,302,000 | 7,760,000 | 7,930,000 | 7,110,000 | 6,136,000 | 5,186,000 | 4,961,000 | 4,221 | 3,363 | 2,381 | 1,514 | 1,149 | ||||||||||||||
yoy | -10.81% | 323.61% | -159.23% | -35.53% | -140.47% | -41.41% | -139.60% | 0.84% | -377.17% | -21.45% | -44.04% | -43.85% | -63.98% | -36.94% | 46.24% | -37.52% | 129.38% | 56.94% | 20.51% | 110.96% | 3.25% | 1.50% | 8.80% | 1.49% | 15.57% | 115.18% | 640.58% | 79.75% | 27.48% | -58.23% | 140.68% | 34.12% | -0.28% | -118.13% | -0.26% | 41.74% | 178.43% | -109.37% | 315.10% | -686.50% | -1018.24% | -76.80% | -60.96% | -102.36% | -63.31% | -64.35% | -2042.85% | -32.92% | -58.39% | -39.47% | -7.85% | 36.22% | 53.35% | 72.30% | 64.22% | 16.21% | 36.65% | 24.12% | 91.46% | 64.77% | 82.11% | 36.07% | 14.16% | 2.45% | 19.00% | 49.63% | 59.85% | 168343.50% | 182356.14% | 217707.64% | 327575.03% | 267.36% | |||||||||||||||||||
qoq | -53.01% | 185.57% | 31.09% | -49.30% | 123.19% | -139.93% | -242.69% | -131.83% | -423.10% | -73.01% | 263.33% | -12.52% | -8.44% | -80.77% | 264.51% | -43.88% | 60.30% | -55.40% | 55.74% | 106.02% | 9.68% | -65.76% | 172.64% | 0.84% | 7.81% | -5.94% | 22.77% | 223.71% | -70.20% | 6.07% | 71.70% | -21.13% | -131.22% | 12.07% | -161.32% | -5066.34% | -13.36% | 25.47% | 45.82% | -2051.53% | 41.68% | -32.62% | -12.12% | 2.57% | 29.90% | 15.25% | 23.81% | 35.52% | 12.45% | 16.64% | 24.29% | -0.25% | -5.90% | -2.14% | 11.53% | 15.87% | 18.32% | 4.54% | 117431.39% | 25.51% | 41.24% | 57.27% | 31.77% | ||||||||||||||||||||||||||||
net income attributable to noncontrolling interests | -968,000 | -809,000 | -42,000 | -855,000 | -239,000 | -470,000 | -422,000 | -1,146,000 | -430,000 | -473,000 | -244,000 | -881,000 | -193,000 | -298,000 | -269,000 | -171,000 | -192,000 | -161,000 | -103,000 | -68,000 | -69,000 | -66,000 | -147,000 | -102,000 | -135,000 | -73,000 | -84,000 | -55,000 | -36,000 | -174,000 | -164,000 | -184,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net income attributable to amedisys, inc. | 28,084,000 | 61,012,000 | 26,320,000 | 16,911,000 | 32,301,000 | 14,400,000 | -35,707,000 | 25,960,000 | -80,275,000 | 25,246,000 | 92,967,000 | 25,642,000 | 29,579,000 | 31,671,000 | 164,066,000 | 45,006,000 | 80,149,000 | 49,870,000 | 111,627,000 | 71,981,000 | 34,674,000 | 31,802,000 | 92,701,000 | 34,132,000 | 33,742,000 | 31,304,000 | 31,377,000 | 33,349,000 | 27,159,000 | 14,558,000 | 4,461,000 | 15,130,000 | 11,435,000 | 10,696,000 | 6,213,000 | 8,440,000 | 10,637,000 | 8,439,000 | 7,619,000 | -12,417,000 | -91,069,000 | 1,841,000 | 2,679,000 | 9,922,000 | 7,882,000 | 5,420,000 | -423,722,000 | 21,656,000 | 15,288,000 | 21,634,000 | 32,202,000 | 36,646,000 | 35,940,000 | 35,083,000 | 27,022,000 | ||||||||||||||||||||||||||||||||||||
basic earnings per common share: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net income attributable to amedisys, inc. common stockholders | 850 | 1,860 | 800 | 520 | 990 | 440 | -1,100 | 800 | -2,460 | 780 | 2,860 | 790 | 910 | 970 | 5,030 | 1,380 | 2,460 | 1,520 | 3,440 | 2,200 | 1,070 | 980 | 2,890 | 1,060 | 1,050 | 980 | 990 | 1,000 | 800 | 430 | 130 | 450 | 340 | 320 | 190 | 250 | 320 | 260 | 240 | -390 | -2,890 | 60 | 90 | 330 | 260 | 180 | |||||||||||||||||||||||||||||||||||||||||||||
weighted-average shares outstanding | 32,849,000 | 32,793,000 | 32,718,000 | 32,745,000 | 32,706,000 | 32,670,000 | 32,599,000 | 32,624,000 | 32,579,000 | 32,558,000 | 32,517,000 | 32,482,000 | 32,522,000 | 32,555,000 | 32,642,000 | 32,607,000 | 32,588,000 | 32,780,000 | 32,559,000 | 32,662,000 | 32,412,000 | 32,331,000 | 32,142,000 | 32,211,000 | 32,075,000 | 32,001,000 | 32,791,000 | 31,815,000 | 33,439,000 | 33,971,000 | 33,704,000 | 33,838,000 | 33,637,000 | 33,443,000 | 33,198,000 | 33,309,000 | 33,197,000 | 32,920,000 | 33,018,000 | 33,128,000 | 33,004,000 | 32,739,000 | 32,301,000 | 32,468,000 | 32,251,000 | 31,864,000 | 31,247,000 | 31,505,000 | 31,160,000 | 30,640,000 | 29,896,000 | 30,055,000 | 29,780,000 | 29,389,000 | 28,693,000 | ||||||||||||||||||||||||||||||||||||
diluted earnings per common share: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
merger termination fee | -106,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total other expense | -6,980,000 | -1,342,000 | -2,984,000 | -4,392,000 | -1,066,000 | -4,264,000 | -100,026,000 | -7,670,000 | -4,230,000 | -642,000 | -276,000 | -1,104,000 | -4,754,000 | -2,478,000 | -43,000 | -208,000 | -278,000 | 111,000 | -673,000 | -1,596,000 | -1,713,000 | -1,325,000 | -2,020,000 | -2,124,000 | -2,150,000 | -1,357,000 | -3,099,000 | -1,337,000 | -1,675,000 | -1,963,000 | 195,000 | -79,000 | -59,000 | -76 | -255 | -5 | -118 | -333 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
net loss attributable to noncontrolling interests | 4,672,000 | 397,000 | -272,000 | -194,000 | 845,000 | 344,000 | 206,000 | 337,000 | 671,000 | 239,000 | 542,000 | -236,000 | -177,000 | -158,000 | -52,000 | 93,000 | 709,000 | -7,000 | 546,000 | -86,000 | -39,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
investment impairment | 752,250 | 3,009,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other operating income | 13,304,000 | -4,000 | 4,603,000 | 8,701,000 | 29,560,000 | 4,812,000 | 22,780,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cost of service, excluding depreciation and amortization | 938,198,000 | 322,227,000 | 316,211,000 | 304,820,000 | 923,062,000 | 310,294,000 | 308,691,000 | 297,203,000 | 887,701,000 | 297,668,000 | 295,228,000 | 285,737,000 | 861,629,000 | 288,708,000 | 290,752,000 | 275,274,000 | 249,739,000 | 242,564,000 | 238,309,000 | 226,642,000 | 219,765,000 | 215,785,000 | 212,124,000 | 206,505,000 | 201,837,000 | 186,772,000 | 175,699,000 | 170,961,000 | 170,159,000 | 172,520,000 | 177,008,000 | 175,483,000 | 176,077,000 | 192,504,000 | 214,131,000 | 212,266,000 | 208,506,000 | 205,657,000 | 193,147,000 | 191,179,000 | 206,312,000 | 209,302,000 | 204,062,000 | 183,619,000 | 178,437,000 | 165,039,000 | 151,122,000 | 148,754,000 | 100,768,000 | 79,300,000 | 74,657,000 | 67,034,000 | 59,877,000 | 56,664,000 | |||||||||||||||||||||||||||||||||||||
operating expenses | 1,523,370,000 | 519,057,000 | 510,249,000 | 497,295,000 | 1,478,788,000 | 496,709,000 | 490,634,000 | 476,996,000 | 1,401,054,000 | 485,569,000 | 457,907,000 | 447,815,000 | 1,330,374,000 | 447,787,000 | 448,233,000 | 423,016,000 | 377,447,000 | 368,775,000 | 363,257,000 | 356,790,000 | 378,581,000 | 345,293,000 | 347,236,000 | 342,388,000 | 337,754,000 | 309,735,000 | 298,625,000 | 359,676,000 | 284,033,000 | 292,445,000 | 318,312,000 | 455,931,000 | 309,355,000 | 335,006,000 | 360,944,000 | 362,949,000 | 358,376,000 | 932,178,000 | 335,712,000 | 336,821,000 | 367,572,000 | 366,221,000 | 351,253,000 | 327,523,000 | 318,352,000 | 294,919,000 | 277,923,000 | 273,918,000 | 185,249,000 | 155,174,000 | 132,889,000 | ||||||||||||||||||||||||||||||||||||||||
gain on equity method investments | 31,092,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income tax benefit | -2,682,750 | -10,731,000 | 2,550,500 | 10,202,000 | -10,596,000 | 1,963,000 | -6,693,000 | -7,242,000 | -4,388,000 | -6,465,000 | -7,566,000 | 21,591,000 | -5,358,000 | -4,743,000 | 7,618,000 | 56,962,000 | -3,049,000 | 135,640,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
securities class action lawsuit settlement | 28,712,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
provision for doubtful accounts | 7,086,000 | 4,651,000 | 6,341,000 | 5,471,000 | 4,253,000 | 3,940,000 | 3,638,000 | 2,756,000 | 2,976,000 | 4,183,000 | 4,242,000 | 4,894,000 | 3,971,000 | 4,658,000 | 3,967,000 | 5,677,000 | 4,695,000 | 5,863,000 | 4,628,000 | 2,128,000 | 3,162,000 | 5,261,000 | 4,463,000 | 4,345,000 | 4,578,000 | 5,737,000 | 6,228,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other expense: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
equity in loss from equity method investments | -106,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
asset impairment charge | 2,075,000 | 75,193,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
equity in earnings from equity investments | 1,924,000 | 4,826,000 | 1,951,000 | 563,000 | 885,000 | 787,000 | 354,000 | 337,000 | 363,000 | 390,000 | 396,000 | 305,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income from continuing operations | 8,575,000 | 10,873,000 | 8,597,000 | 7,610,000 | -12,233,000 | -91,092,000 | 2,338,000 | 2,133,000 | 10,036,000 | 8,094,000 | 6,512,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
discontinued operations, net of tax | 61,000 | -277,000 | -686,000 | -490,000 | -41,000 | -128,000 | -1,049,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income from continuing operations attributable to amedisys, inc. common stockholders | 250 | 320 | 260 | 240 | -380 | -2,870 | 70 | 90 | 330 | 270 | 220 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
amounts attributable to amedisys, inc. common stockholders: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
loss from continuing operations | -34,832,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net loss attributable to amedisys, inc. | -35,009,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic and diluted earnings per common share: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
loss from continuing operations attributable to amedisys, inc. common stockholders | -1,070 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net loss attributable to amedisys, inc. common stockholders | -1,070 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
u.s. department of justice settlement | 150,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other intangibles impairment charge | 2,208,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
gain on sale of care centers | 1,451,000 | 357,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
goodwill and other intangibles impairment charge | 574,114,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net (income) attributable to noncontrolling interests | -43,000 | -25,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
equity in earnings from unconsolidated joint ventures | 325,000 | 466,000 | 323,000 | 788,000 | 734,000 | 788,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net income per share | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic | -14.73 | 0.76 | 0.54 | 0.77 | 1.15 | 1.32 | 880 | 770 | 630 | 780 | 580 | 520 | 660 | 570 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
diluted | -14.73 | 0.75 | 0.53 | 0.76 | 1.13 | 1.29 | 870 | 760 | 620 | 770 | 570 | 510 | 640 | 550 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
weighted-average shares outstanding: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic | 28,770 | 28,625 | 28,366 | 28,032 | 28,096 | 28,106 | 27,821 | 27,231 | 27,340,000 | 27,124,000 | 26,854,000 | 26,445,000 | 26,556,000 | 26,341,000 | 26,191,000 | 25,842,000 | 25,899,000 | 25,774,000 | 25,634,000 | 21,809,000 | 16,101,000 | 15,976,000 | 15,902 | 15,606 | 15,390,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
diluted | 28,770 | 29,010 | 28,867 | 28,484 | 28,499 | 28,597 | 28,359 | 27,759 | 27,912,000 | 27,541,000 | 27,293,000 | 26,903,000 | 27,018,000 | 26,811,000 | 26,645,000 | 26,275,000 | 26,332,000 | 26,196,000 | 26,041,000 | 22,289,000 | 16,446,000 | 16,326,000 | 16,283 | 15,970 | 15,740,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net income attributable to amedisys, inc. common stockholders: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic | 1,310 | 1,290 | 1,010 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
diluted | 1,290 | 1,270 | 990 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
benefit from doubtful accounts | 6,166,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net (income) loss attributable to noncontrolling interests | -15,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net income attributable to amedisys, inc. common shareholders: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic | 1,310 | 1,290 | 1,010 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
diluted | 1,290 | 1,270 | 990 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
gain on release of alliance’s net liabilities | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income before income taxes and minority interest | 38,619,000 | 33,723,000 | 27,209,000 | 30,597,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
minority interests | 18,000 | -2,000 | 27,000 | 10,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net income per common share: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic | -14.73 | 0.76 | 0.54 | 0.77 | 1.15 | 1.32 | 880 | 770 | 630 | 780 | 580 | 520 | 660 | 570 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
diluted | -14.73 | 0.75 | 0.53 | 0.76 | 1.13 | 1.29 | 870 | 760 | 620 | 770 | 570 | 510 | 640 | 550 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
equity in earnings of unconsolidated joint ventures | -43,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
alliance | 4,212,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
operating expense | 145,416,000 | 118,876,000 | 117,221,000 | 114,467,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
weighted-average common shares outstanding: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic | 28,770 | 28,625 | 28,366 | 28,032 | 28,096 | 28,106 | 27,821 | 27,231 | 27,340,000 | 27,124,000 | 26,854,000 | 26,445,000 | 26,556,000 | 26,341,000 | 26,191,000 | 25,842,000 | 25,899,000 | 25,774,000 | 25,634,000 | 21,809,000 | 16,101,000 | 15,976,000 | 15,902 | 15,606 | 15,390,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
diluted | 28,770 | 29,010 | 28,867 | 28,484 | 28,499 | 28,597 | 28,359 | 27,759 | 27,912,000 | 27,541,000 | 27,293,000 | 26,903,000 | 27,018,000 | 26,811,000 | 26,645,000 | 26,275,000 | 26,332,000 | 26,196,000 | 26,041,000 | 22,289,000 | 16,446,000 | 16,326,000 | 16,283 | 15,970 | 15,740,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cost of service | 55,770,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
general and administrative: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
earnings per share: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic | 0.46 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
diluted | 0.45 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cost of service revenue | 52,515,000 | 49,011,000 | 33,044,000 | 28,461,000 | 27,332,000 | 25,653,000 | 23,613,000 | 19,480 | 17,346 | 15,199 | 13,100 | 12,909 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
gross margin | 66,378,000 | 63,155,000 | 47,017,000 | 41,976,000 | 37,028,000 | 32,841,000 | 33,283,000 | 27,859 | 24,753 | 21,849 | 19,094 | 18,223 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
yoy | 79.26% | 92.31% | 41.26% | 150573.03% | 149489.95% | 150208.94% | 174211.30% | 52.88% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
qoq | 5.10% | 34.32% | 12.01% | 13.36% | 12.75% | -1.33% | 119369.47% | 12.55% | 13.29% | 14.43% | 4.78% | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total general and administrative expenses | 54,538,000 | 49,126,000 | 34,296,000 | 30,464,000 | 27,078,000 | 24,401,000 | 25,200,000 | 20,954 | 19,047 | 17,957 | 16,538 | 16,039 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total other (expense) | -159,500 | -1,223,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic weighted-average common shares outstanding | 15,692,000 | 15,509,000 | 13,057,000,000 | 12,669,000 | 12,281,000 | 12,006,000 | 9,808,000 | 9,713 | 9,477 | 9,327,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic income per common share: | 365 | 490 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
diluted weighted-average common shares outstanding | 16,064,000 | 15,837,000 | 13,543,000,000 | 13,136,000 | 12,804,000 | 12,536,000 | 10,074,000 | 10,108 | 9,666 | 9,501,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
diluted income per common share: | 360 | 480 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
earnings per common share: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic | 460 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
diluted | 450 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
weighted-average common shares outstanding | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic | 28,770 | 28,625 | 28,366 | 28,032 | 28,096 | 28,106 | 27,821 | 27,231 | 27,340,000 | 27,124,000 | 26,854,000 | 26,445,000 | 26,556,000 | 26,341,000 | 26,191,000 | 25,842,000 | 25,899,000 | 25,774,000 | 25,634,000 | 21,809,000 | 16,101,000 | 15,976,000 | 15,902 | 15,606 | 15,390,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
diluted | 28,770 | 29,010 | 28,867 | 28,484 | 28,499 | 28,597 | 28,359 | 27,759 | 27,912,000 | 27,541,000 | 27,293,000 | 26,903,000 | 27,018,000 | 26,811,000 | 26,645,000 | 26,275,000 | 26,332,000 | 26,196,000 | 26,041,000 | 22,289,000 | 16,446,000 | 16,326,000 | 16,283 | 15,970 | 15,740,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other income and expense: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other income | 120.5 | 273 | 199 | 10 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic income per common share | 0.133 | 0.25 | 0.16 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
diluted income per common share | 0.13 | 0.24 | 0.16 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
basic net income per common share | 0.12 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
diluted net income per common share | 0.12 |
Balance Sheets:
Quarterly
Annual
| Unit: USD | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-12-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-12-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-12-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-12-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-12-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-12-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-12-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-12-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-12-31 | 2014-09-30 | 2014-06-30 | 2014-03-31 | 2013-12-31 | 2013-09-30 | 2013-06-30 | 2013-03-31 | 2012-12-31 | 2012-09-30 | 2012-06-30 | 2012-03-31 | 2011-12-31 | 2011-09-30 | 2011-06-30 | 2011-03-31 | 2010-12-31 | 2010-09-30 | 2010-06-30 | 2010-03-31 | 2009-12-31 | 2009-09-30 | 2009-06-30 | 2009-03-31 | 2008-12-31 | 2008-09-30 | 2008-06-30 | 2008-03-31 | 2007-12-31 | 2007-09-30 | 2007-06-30 | 2007-03-31 | 2006-12-31 | 2006-09-30 | 2006-06-30 | 2006-03-31 | 2005-12-31 | 2005-09-30 | 2005-06-30 | 2005-03-31 | 2004-12-31 | 2004-09-30 | 2004-06-30 | 2004-03-31 | 2003-12-31 | 2003-09-30 | 2003-06-30 | 2003-03-31 | 2002-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
assets | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
current assets: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents | 337,304,000 | 284,881,000 | 303,242,000 | 245,450,000 | 149,883,000 | 108,234,000 | 126,450,000 | 78,112,000 | 95,377,000 | 49,436,000 | 40,540,000 | 17,956,000 | 26,566,000 | 67,834,000 | 42,694,000 | 124,458,000 | 91,646,000 | 77,344,000 | 81,808,000 | 112,904,000 | 177,278,000 | 174,756,000 | 30,294,000 | 20,757,000 | 13,902,000 | 10,554,000 | 20,229,000 | 14,010,000 | 25,904,000 | 120,005,000 | 86,363,000 | 66,114,000 | 59,164,000 | 48,334,000 | 30,197,000 | 8,915,000 | 9,968,000 | 7,824,000 | 27,502,000 | 57,051,000 | 33,201,000 | 3,132,000 | 8,032,000 | 5,542,000 | 11,225,000 | 2,840,000 | 17,303,000 | 43,626,000 | 30,118,000 | 7,021,000 | 14,545,000 | 39,106,000 | 37,158,000 | 41,290,000 | 48,004,000 | 29,462,000 | 28,132,000 | 148,868,000 | 120,295,000 | 128,037,000 | 116,027,000 | 81,980,000 | 34,485,000 | 45,160,000 | 898,000 | 25,648,000 | 2,847,000 | 5,664,000 | 1,660,000 | 25,236,000 | 56,190,000 | 66,592,000 | 91,341,000 | 107,483,000 | 84,221,000 | 9,855,000 | 7,957,000 | 9,476,000 | 17,231,000 | 20,750,000 | 72,063,000 | 78,917,000 | 89,679,000 | 93,181,000 | 22,279,000 | 24,338 | 29,779 | 10,064 | 12,801 | 8,341 | 4,861 |
patient accounts receivable | 295,521,000 | 319,639,000 | 296,075,000 | 301,050,000 | 356,909,000 | 359,359,000 | 313,373,000 | 319,580,000 | 278,785,000 | 294,122,000 | 296,785,000 | 302,470,000 | 305,413,000 | 293,579,000 | 274,961,000 | 274,570,000 | 278,216,000 | 275,632,000 | 255,145,000 | 250,777,000 | 249,030,000 | 268,551,000 | 237,596,000 | 254,703,000 | 239,674,000 | 236,437,000 | 188,972,000 | 195,030,000 | 197,592,000 | 192,936,000 | 96,309,000 | 86,553,000 | 75,034,000 | 67,930,000 | 81,109,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
prepaid expenses | 18,282,000 | 17,410,000 | 13,072,000 | 20,485,000 | 15,510,000 | 20,332,000 | 14,639,000 | 20,534,000 | 13,774,000 | 18,754,000 | 11,628,000 | 17,011,000 | 15,199,000 | 17,221,000 | 10,356,000 | 16,080,000 | 11,979,000 | 15,449,000 | 10,217,000 | 14,906,000 | 10,788,000 | 12,487,000 | 8,243,000 | 10,601,000 | 8,957,000 | 10,792,000 | 7,568,000 | 11,679,000 | 10,493,000 | 12,430,000 | 7,329,000 | 9,770,000 | 8,800,000 | 10,097,000 | 7,397,000 | 9,948,000 | 7,931,000 | 9,086,000 | 8,110,000 | 10,402,000 | 7,568,000 | 8,504,000 | 8,493,000 | 11,303,000 | 10,855,000 | 13,675,000 | 10,669,000 | 11,460,000 | 13,369,000 | 14,478,000 | 10,631,000 | 10,646,000 | 11,180,000 | 12,765,000 | 11,321,000 | 10,950,000 | 10,976,000 | 11,605,000 | 9,947,000 | 9,932,000 | 11,713,000 | 12,651,000 | 10,279,000 | 9,199,000 | 8,865,000 | 10,128,000 | 8,086,000 | 7,159,000 | 8,573,000 | 10,714,000 | 6,023,000 | 4,956,000 | 4,786,000 | 5,091,000 | 4,133,000 | 3,222,000 | 4,286,000 | 4,906,000 | 2,693,000 | 2,570,000 | 2,613,000 | 3,572,000 | 1,356,000 | 2,538,000 | 2,268,000 | 2,452 | 1,103 | 1,428 | 1,631 | 1,929 | 1,600 |
other current assets | 11,091,000 | 12,034,000 | 19,694,000 | 12,962,000 | 26,125,000 | 26,053,000 | 30,060,000 | 33,097,000 | 22,824,000 | 23,581,000 | 26,415,000 | 37,839,000 | 25,493,000 | 10,776,000 | 25,598,000 | 14,024,000 | 8,124,000 | 11,025,000 | 13,265,000 | 30,114,000 | 9,395,000 | 9,278,000 | 8,225,000 | 13,458,000 | 13,252,000 | 13,948,000 | 7,349,000 | 11,949,000 | 24,784,000 | 18,148,000 | 16,268,000 | 14,904,000 | 31,789,000 | 11,964,000 | 11,260,000 | 12,070,000 | 9,407,000 | 5,959,000 | 14,641,000 | 5,641,000 | 17,147,000 | 23,556,000 | 19,708,000 | 12,577,000 | 15,185,000 | 14,309,000 | 10,785,000 | 9,819,000 | 12,006,000 | 16,229,000 | 11,440,000 | 20,635,000 | 24,801,000 | 22,072,000 | 24,630,000 | 13,795,000 | 12,400,000 | 15,701,000 | 22,139,000 | 7,838,000 | 10,776,000 | 15,905,000 | 23,003,000 | 5,539,000 | 9,154,000 | 8,727,000 | 7,719,000 | 7,872,000 | 3,903,000 | 3,858,000 | 5,991,000 | 5,847,000 | 4,683,000 | 3,887,000 | 11,125,000 | 2,824,000 | 5,912,000 | 2,366,000 | 4,277,000 | ||||||||||||
total current assets | 662,198,000 | 633,964,000 | 632,083,000 | 579,947,000 | 555,902,000 | 526,448,000 | 496,935,000 | 467,227,000 | 426,544,000 | 405,557,000 | 388,961,000 | 388,780,000 | 394,869,000 | 392,485,000 | 356,684,000 | 432,882,000 | 390,965,000 | 380,450,000 | 361,984,000 | 411,250,000 | 449,540,000 | 468,128,000 | 350,554,000 | 299,519,000 | 275,785,000 | 271,731,000 | 224,118,000 | 232,668,000 | 258,773,000 | 343,519,000 | 311,156,000 | 268,190,000 | 273,141,000 | 243,102,000 | 214,910,000 | 193,433,000 | 179,519,000 | 176,729,000 | 175,263,000 | 216,441,000 | 168,370,000 | 145,843,000 | 135,558,000 | 142,434,000 | 158,911,000 | 203,517,000 | 205,279,000 | 234,410,000 | 181,809,000 | 182,387,000 | 205,788,000 | 233,848,000 | 236,300,000 | 237,961,000 | 232,016,000 | 205,415,000 | 204,781,000 | 318,097,000 | 293,930,000 | 282,257,000 | 290,371,000 | 261,108,000 | 218,036,000 | 200,909,000 | 173,196,000 | 198,871,000 | 194,350,000 | 200,463,000 | 177,074,000 | 183,874,000 | 164,513,000 | 169,881,000 | 181,757,000 | 190,312,000 | 179,205,000 | 97,010,000 | 81,969,000 | 84,150,000 | 92,340,000 | 92,030,000 | 114,900,000 | 110,175,000 | 118,890,000 | 115,222,000 | 45,511,000 | 43,783 | 49,596 | 26,438 | 26,954 | 23,669 | 22,588 |
property and equipment | 38,273,000 | 40,186,000 | 42,108,000 | 42,000,000 | 44,654,000 | 42,684,000 | 41,845,000 | 39,631,000 | 36,399,000 | 33,353,000 | 16,026,000 | 17,248,000 | 17,847,000 | 17,295,000 | 18,435,000 | 20,381,000 | 20,986,000 | 21,679,000 | 23,719,000 | 24,104,000 | 25,007,000 | 26,477,000 | 28,113,000 | 29,969,000 | 29,762,000 | 29,716,000 | 29,449,000 | 30,215,000 | 27,998,000 | 28,213,000 | 31,122,000 | 32,695,000 | 34,420,000 | 36,676,000 | 36,999,000 | 42,960,000 | 44,617,000 | 43,963,000 | 42,695,000 | 41,485,000 | 66,953,000 | 57,088,000 | 137,455,000 | 141,419,000 | 148,346,000 | 157,034,000 | 159,025,000 | 160,077,000 | 156,887,000 | 156,481,000 | 156,709,000 | 150,947,000 | 146,207,000 | 143,965,000 | 148,536,000 | 146,928,000 | 144,446,000 | 144,023,000 | 138,554,000 | 117,820,000 | 112,143,000 | 95,440,000 | 91,919,000 | 87,021,000 | 82,644,000 | 80,740,000 | 79,258,000 | 80,387,000 | 78,504,000 | 75,397,000 | 68,313,000 | 66,709,000 | 66,896,000 | 55,401,000 | 52,960,000 | 42,857,000 | 36,700,000 | 30,282,000 | 27,389,000 | 24,315,000 | 19,825,000 | 14,677,000 | 10,003,000 | 9,127,000 | 8,121,000 | 7,239 | 7,219 | 6,919 | 7,378 | 7,815 | 8,257 |
operating lease right of use assets | 86,614,000 | 80,905,000 | 81,500,000 | 85,110,000 | 84,692,000 | 88,425,000 | 88,939,000 | 87,834,000 | 85,142,000 | 85,211,000 | 102,856,000 | 105,843,000 | 107,723,000 | 102,801,000 | 101,257,000 | 100,028,000 | 95,034,000 | 94,620,000 | 93,440,000 | 94,273,000 | 92,904,000 | 83,693,000 | 84,791,000 | 84,124,000 | 85,026,000 | 83,064,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
goodwill | 1,213,888,000 | 1,213,888,000 | 1,213,888,000 | 1,244,679,000 | 1,244,679,000 | 1,244,679,000 | 1,244,679,000 | 1,244,679,000 | 1,244,679,000 | 1,244,679,000 | 1,287,399,000 | 1,285,455,000 | 1,289,672,000 | 1,204,638,000 | 1,196,090,000 | 1,188,054,000 | 936,772,000 | 933,207,000 | 932,685,000 | 931,483,000 | 937,088,000 | 721,049,000 | 658,500,000 | 660,472,000 | 664,822,000 | 649,514,000 | 329,480,000 | 324,145,000 | 324,145,000 | 322,199,000 | 319,949,000 | 313,663,000 | 313,663,000 | 292,793,000 | 288,957,000 | 284,552,000 | 280,349,000 | 285,124,000 | 261,663,000 | 211,109,000 | 205,587,000 | 205,587,000 | 205,587,000 | 205,587,000 | 205,587,000 | 208,923,000 | 208,915,000 | 208,126,000 | 209,260,000 | 209,994,000 | 209,594,000 | 367,495,000 | 343,353,000 | 334,695,000 | 334,695,000 | 335,811,000 | 901,611,000 | 791,412,000 | 791,412,000 | 790,409,000 | 790,210,000 | 789,054,000 | 786,923,000 | 765,137,000 | 749,238,000 | 736,253,000 | 733,881,000 | 701,113,000 | 697,545,000 | 734,187,000 | 332,534,000 | 307,375,000 | 249,632,000 | 219,061,000 | 213,032,000 | 210,337,000 | 207,775,000 | 201,218,000 | 197,002,000 | 194,502,000 | 85,120,000 | 80,065,000 | 62,537,000 | ||||||||
intangible assets, net of accumulated amortization of 21,134 and 18,787 | 79,243,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other assets | 135,169,000 | 135,432,000 | 87,980,000 | 87,680,000 | 86,609,000 | 85,857,000 | 85,097,000 | 84,412,000 | 84,894,000 | 78,230,000 | 79,836,000 | 81,123,000 | 84,686,000 | 84,639,000 | 73,023,000 | 68,105,000 | 64,103,000 | 32,913,000 | 33,200,000 | 33,278,000 | 33,673,000 | 52,287,000 | 54,612,000 | 54,260,000 | 58,288,000 | 54,888,000 | 54,145,000 | 53,406,000 | 50,601,000 | 49,856,000 | 49,130,000 | 48,976,000 | 38,320,000 | 38,894,000 | 38,468,000 | 39,741,000 | 37,875,000 | 34,914,000 | 36,172,000 | 34,259,000 | 30,845,000 | 35,051,000 | 33,161,000 | 30,199,000 | 28,898,000 | 27,589,000 | 26,283,000 | 26,501,000 | 23,932,000 | 24,855,000 | 18,650,000 | 16,963,000 | 23,606,000 | 23,721,000 | 24,322,000 | 29,190,000 | 27,478,000 | 21,780,000 | 22,536,000 | 17,536,000 | 18,764,000 | 17,750,000 | 17,865,000 | 20,512,000 | 20,988,000 | 19,746,000 | 20,317,000 | 24,280,000 | 24,719,000 | 16,401,000 | 7,450,000 | 6,871,000 | 6,725,000 | 5,600,000 | 5,826,000 | 7,147,000 | 7,037,000 | 12,444,000 | 11,819,000 | 5,777,000 | 6,042,000 | 6,188,000 | 3,856,000 | 34,331 | 25,737 | 25,748 | |||||
total assets | 2,215,385,000 | 2,184,574,000 | 2,138,714,000 | 2,139,114,000 | 2,117,368,000 | 2,089,871,000 | 2,060,170,000 | 2,027,417,000 | 1,982,402,000 | 1,946,959,000 | 1,976,245,000 | 1,982,127,000 | 2,000,986,000 | 1,908,392,000 | 1,856,968,000 | 1,937,645,000 | 1,599,563,000 | 1,573,209,000 | 1,567,198,000 | 1,602,720,000 | 1,645,488,000 | 1,440,084,000 | 1,262,745,000 | 1,212,380,000 | 1,205,862,000 | 1,184,239,000 | 717,118,000 | 725,892,000 | 753,324,000 | 842,288,000 | 813,482,000 | 799,529,000 | 805,873,000 | 756,628,000 | 734,029,000 | 721,732,000 | 711,102,000 | 705,645,000 | 685,085,000 | 666,436,000 | 645,433,000 | 623,327,000 | 669,742,000 | 682,213,000 | 710,296,000 | 727,390,000 | 726,406,000 | 754,569,000 | 700,253,000 | 712,317,000 | 730,595,000 | 875,724,000 | 858,299,000 | 855,380,000 | 858,285,000 | 846,776,000 | 1,340,647,000 | 1,327,560,000 | 1,299,825,000 | 1,263,922,000 | 1,269,220,000 | 1,222,445,000 | 1,172,351,000 | 1,130,940,000 | 1,083,398,000 | 1,086,401,000 | 1,070,194,000 | 1,050,723,000 | 1,022,450,000 | 1,037,747,000 | 587,111,000 | 564,727,000 | 518,671,000 | 483,115,000 | 463,756,000 | 370,188,000 | 347,680,000 | 339,511,000 | 339,997,000 | 330,605,000 | 232,919,000 | 217,726,000 | 199,733,000 | 187,914,000 | 111,015,000 | 106,128 | 92,473 | 67,688 | 60,069 | 58,006 | 58,324 |
liabilities and equity | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
current liabilities: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accounts payable | 29,789,000 | 28,705,000 | 39,956,000 | 32,117,000 | 26,626,000 | 36,249,000 | 28,237,000 | 34,555,000 | 38,557,000 | 40,017,000 | 43,735,000 | 45,527,000 | 43,509,000 | 36,621,000 | 38,217,000 | 41,649,000 | 36,668,000 | 38,865,000 | 42,674,000 | 39,037,000 | 33,383,000 | 31,147,000 | 31,259,000 | 35,901,000 | 35,690,000 | 32,797,000 | 28,531,000 | 24,519,000 | 29,810,000 | 22,966,000 | 25,384,000 | 22,815,000 | 29,119,000 | 29,444,000 | 30,358,000 | 33,088,000 | 35,070,000 | 33,627,000 | 25,682,000 | 24,226,000 | 21,911,000 | 23,651,000 | 16,056,000 | 19,363,000 | 18,886,000 | 24,198,000 | 20,139,000 | 24,362,000 | 21,658,000 | 27,646,000 | 29,175,000 | 21,690,000 | 24,425,000 | 20,532,000 | 25,475,000 | 22,347,000 | 21,843,000 | 21,290,000 | 23,374,000 | 19,551,000 | 22,968,000 | 21,554,000 | 16,535,000 | 18,999,000 | 17,391,000 | 18,528,000 | 18,652,000 | 15,535,000 | 19,681,000 | 21,520,000 | 14,438,000 | 14,370,000 | 10,533,000 | 10,916,000 | 14,339,000 | 13,643,000 | 13,527,000 | 7,919,000 | 29,922,000 | 10,170,000 | 4,521,000 | 4,419,000 | 6,681,000 | 3,674,000 | 3,255,000 | 5,009 | 3,340 | 2,411 | 2,029 | 1,776 | 2,495 |
payroll and employee benefits | 138,515,000 | 131,722,000 | 151,995,000 | 138,374,000 | 136,118,000 | 131,631,000 | 136,835,000 | 126,989,000 | 123,234,000 | 122,723,000 | 125,387,000 | 145,073,000 | 161,068,000 | 151,279,000 | 141,001,000 | 155,123,000 | 147,017,000 | 150,887,000 | 146,929,000 | 126,543,000 | 128,275,000 | 109,713,000 | 120,877,000 | 115,899,000 | 111,660,000 | 111,312,000 | 92,858,000 | 92,385,000 | 87,239,000 | 88,585,000 | 89,936,000 | 86,139,000 | 81,331,000 | 81,909,000 | 82,480,000 | 78,754,000 | 86,075,000 | 82,837,000 | 72,546,000 | 74,050,000 | 74,688,000 | 69,791,000 | 75,553,000 | 71,208,000 | 72,861,000 | 76,066,000 | 70,801,000 | 68,923,000 | 76,205,000 | 78,919,000 | 79,341,000 | 81,751,000 | 86,590,000 | 87,334,000 | 82,130,000 | 77,038,000 | 78,077,000 | 88,322,000 | 100,700,000 | 117,200,000 | 119,549,000 | 124,832,000 | |||||||||||||||||||||||||||||
accrued expenses | 150,379,000 | 162,180,000 | 152,564,000 | 145,611,000 | 147,038,000 | 147,464,000 | 140,049,000 | 139,100,000 | 137,359,000 | 137,899,000 | 137,390,000 | 130,100,000 | 176,239,000 | 148,044,000 | 150,836,000 | 154,264,000 | 166,157,000 | 170,954,000 | 166,192,000 | 170,743,000 | 169,722,000 | 136,659,000 | 137,111,000 | 127,111,000 | 131,860,000 | 121,716,000 | 99,475,000 | 101,177,000 | 96,472,000 | 88,842,000 | 89,104,000 | 83,516,000 | 62,981,000 | 65,663,000 | 63,290,000 | 65,112,000 | 63,641,000 | 63,903,000 | 71,965,000 | 69,188,000 | 64,101,000 | 56,763,000 | 56,329,000 | 53,494,000 | 61,712,000 | 61,498,000 | 57,572,000 | 54,340,000 | 54,175,000 | 57,054,000 | 54,855,000 | 64,460,000 | 62,218,000 | 65,845,000 | 68,493,000 | 67,939,000 | 70,014,000 | 69,321,000 | 36,149,000 | 33,746,000 | 36,650,000 | 35,592,000 | 152,654,000 | 158,527,000 | 144,115,000 | 128,253,000 | 134,049,000 | 121,497,000 | 111,978,000 | 95,806,000 | 66,667,000 | 66,286,000 | 58,549,000 | 53,833,000 | 46,587,000 | 53,273,000 | 51,672,000 | 49,415,000 | 45,165,000 | ||||||||||||
termination fee paid by unitedhealth group | 106,000,000 | 106,000,000 | 106,000,000 | 106,000,000 | 106,000,000 | 106,000,000 | 106,000,000 | 106,000,000 | 106,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
current portion of long-term obligations | 36,799,000 | 37,579,000 | 37,968,000 | 37,478,000 | 37,747,000 | 37,232,000 | 36,314,000 | 35,364,000 | 31,465,000 | 26,958,000 | 15,496,000 | 12,628,000 | 12,521,000 | 12,309,000 | 12,995,000 | 13,225,000 | 10,160,000 | 10,329,000 | 10,496,000 | 10,711,000 | 10,718,000 | 11,122,000 | 9,927,000 | 8,959,000 | 7,610,000 | 6,038,000 | 1,612,000 | 1,209,000 | 668,000 | 10,417,000 | 10,638,000 | 9,387,000 | 8,137,000 | 6,888,000 | 5,220,000 | 5,220,000 | 5,000,000 | 20,000,000 | 5,000,000 | 3,750,000 | 12,000,000 | 12,000,000 | 12,000,000 | 12,000,000 | 12,277,000 | 12,952,000 | 13,904,000 | 34,855,000 | 35,807,000 | 35,807,000 | 35,807,000 | 54,307,000 | 60,700,000 | 68,513,000 | 33,888,000 | 33,525,000 | 35,448,000 | 36,101,000 | 37,178,000 | 39,265,000 | 41,773,000 | 40,581,000 | 44,254,000 | 43,779,000 | 44,795,000 | 42,451,000 | 42,632,000 | 43,716,000 | 42,739,000 | 41,496,000 | 11,049,000 | 10,356,000 | 7,237,000 | 3,779,000 | 3,223,000 | 11,416,000 | 11,194,000 | 9,881,000 | |||||||||||||
current portion of operating lease liabilities | 26,879,000 | 25,845,000 | 25,909,000 | 26,441,000 | 26,447,000 | 26,284,000 | 26,286,000 | 26,111,000 | 25,786,000 | 25,453,000 | 33,521,000 | 33,872,000 | 34,035,000 | 31,901,000 | 31,233,000 | 31,553,000 | 30,893,000 | 30,047,000 | 30,046,000 | 30,462,000 | 29,950,000 | 27,465,000 | 27,769,000 | 26,783,000 | 26,187,000 | 25,514,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total current liabilities | 488,361,000 | 492,031,000 | 514,392,000 | 486,021,000 | 479,976,000 | 484,860,000 | 473,721,000 | 468,119,000 | 462,401,000 | 353,050,000 | 355,529,000 | 367,200,000 | 427,372,000 | 380,154,000 | 374,282,000 | 454,349,000 | 449,223,000 | 456,082,000 | 456,337,000 | 437,496,000 | 442,048,000 | 316,106,000 | 326,943,000 | 314,653,000 | 313,007,000 | 297,377,000 | 222,476,000 | 219,290,000 | 214,189,000 | 210,810,000 | 215,062,000 | 201,857,000 | 225,318,000 | 183,904,000 | 181,348,000 | 182,174,000 | 189,786,000 | 200,367,000 | 175,193,000 | 171,214,000 | 176,029,000 | 164,234,000 | 162,323,000 | 191,065,000 | 200,736,000 | 324,714,000 | 312,416,000 | 332,480,000 | 191,014,000 | 202,821,000 | 204,787,000 | 231,457,000 | 245,004,000 | 252,417,000 | 221,734,000 | 209,508,000 | 215,790,000 | 227,728,000 | 216,304,000 | 218,627,000 | 238,237,000 | 238,623,000 | 229,306,000 | 232,584,000 | 217,263,000 | 197,316,000 | 204,627,000 | 192,908,000 | 179,029,000 | 173,162,000 | 101,736,000 | 107,167,000 | 91,484,000 | 82,735,000 | 81,918,000 | 92,124,000 | 88,739,000 | 90,941,000 | 99,955,000 | 87,115,000 | 52,425,000 | 48,136,000 | 41,976,000 | 40,004,000 | 40,574,000 | 41,873 | 34,018 | 33,031 | 31,056 | 30,547 | 31,120 |
long-term obligations, less current portion | 326,425,000 | 332,947,000 | 339,313,000 | 344,428,000 | 351,442,000 | 356,080,000 | 361,862,000 | 366,853,000 | 369,896,000 | 373,202,000 | 419,420,000 | 443,431,000 | 442,413,000 | 429,453,000 | 432,075,000 | 434,781,000 | 179,415,000 | 231,380,000 | 204,511,000 | 300,576,000 | 392,713,000 | 379,942,000 | 232,256,000 | 231,641,000 | 266,468,000 | 303,733,000 | 5,775,000 | 54,853,000 | 123,937,000 | 75,782,000 | 78,203,000 | 80,523,000 | 83,157,000 | 85,472,000 | 87,809,000 | 88,874,000 | 89,500,000 | 90,565,000 | 95,000,000 | 96,250,000 | 83,517,000 | 86,444,000 | 104,372,000 | 102,299,000 | 132,000,000 | 30,000,000 | 33,000,000 | 36,000,000 | 39,000,000 | 42,952,000 | 66,904,000 | 67,856,000 | 67,701,000 | 68,376,000 | 111,551,000 | 119,726,000 | 127,901,000 | 136,138,000 | 144,688,000 | 153,414,000 | 162,349,000 | 162,799,000 | 170,899,000 | 179,440,000 | 196,904,000 | 268,407,000 | 285,942,000 | 316,015,000 | 336,458,000 | 375,932,000 | 12,991,000 | 13,325,000 | 8,064,000 | 2,114,000 | |||||||||||||||||
operating lease liabilities, less current portion | 60,404,000 | 55,642,000 | 56,111,000 | 59,323,000 | 59,007,000 | 62,220,000 | 62,751,000 | 61,878,000 | 59,634,000 | 59,826,000 | 69,504,000 | 72,030,000 | 72,619,000 | 70,295,000 | 69,309,000 | 67,723,000 | 63,152,000 | 63,359,000 | 61,987,000 | 62,519,000 | 61,611,000 | 54,926,000 | 56,128,000 | 56,619,000 | 57,392,000 | 55,840,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
deferred income tax liabilities | 64,445,000 | 58,032,000 | 48,051,000 | 48,017,000 | 47,212,000 | 43,229,000 | 40,635,000 | 35,398,000 | 28,085,000 | 22,752,000 | 20,411,000 | 15,983,000 | 6,179,000 | 2,915,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other long-term obligations | 847,000 | 848,000 | 882,000 | 886,000 | 845,000 | 828,000 | 1,418,000 | 1,651,000 | 1,629,000 | 4,781,000 | 4,808,000 | 13,873,000 | 13,408,000 | 4,923,000 | 4,979,000 | 31,991,000 | 31,886,000 | 32,814,000 | 33,622,000 | 44,386,000 | 26,857,000 | 8,966,000 | 5,905,000 | 6,002,000 | 6,053,000 | 6,089,000 | 6,234,000 | 6,253,000 | 6,137,000 | 6,138,000 | 3,791,000 | 3,930,000 | 4,337,000 | 4,306,000 | 3,730,000 | 4,306,000 | 3,991,000 | 3,934,000 | 4,456,000 | 4,998,000 | 5,837,000 | 5,214,000 | 5,285,000 | 5,748,000 | 6,518,000 | 9,761,000 | 8,511,000 | 8,297,000 | 5,209,000 | 4,761,000 | 4,671,000 | 4,431,000 | 4,274,000 | 4,613,000 | 4,852,000 | 5,561,000 | 5,460,000 | 5,291,000 | 6,832,000 | 6,963,000 | 7,074,000 | 5,787,000 | 6,412,000 | 8,654,000 | 8,482,000 | 5,791,000 | 5,959,000 | 6,882,000 | 7,296,000 | 6,086,000 | 6,069,000 | 6,036,000 | 6,841,000 | 5,785,000 | 4,936,000 | 1,298,000 | 1,184,000 | 1,062,000 | |||||||||||||
total liabilities | 940,482,000 | 939,500,000 | 958,749,000 | 938,675,000 | 938,482,000 | 947,217,000 | 940,387,000 | 933,899,000 | 921,645,000 | 813,611,000 | 869,672,000 | 912,517,000 | 961,991,000 | 887,740,000 | 880,645,000 | 988,844,000 | 723,676,000 | 783,635,000 | 756,457,000 | 844,977,000 | 923,229,000 | 759,940,000 | 621,232,000 | 608,915,000 | 642,920,000 | 663,039,000 | 234,485,000 | 280,396,000 | 344,263,000 | 292,730,000 | 297,056,000 | 286,310,000 | 312,812,000 | 273,682,000 | 272,887,000 | 275,354,000 | 283,277,000 | 294,866,000 | 274,649,000 | 272,462,000 | 265,383,000 | 255,892,000 | 271,980,000 | 299,112,000 | 339,254,000 | 364,475,000 | 353,927,000 | 376,777,000 | 235,223,000 | 250,534,000 | 276,362,000 | 303,744,000 | 316,979,000 | 325,406,000 | 338,137,000 | 334,795,000 | 410,667,000 | 423,433,000 | 420,110,000 | 415,701,000 | 441,699,000 | 438,030,000 | 436,016,000 | 444,792,000 | 440,556,000 | 488,299,000 | 508,076,000 | 521,657,000 | 525,685,000 | 568,509,000 | 139,291,000 | 139,749,000 | 119,228,000 | 103,132,000 | 99,749,000 | 138,434,000 | 131,820,000 | 136,575,000 | 147,398,000 | 148,159,000 | 63,349,000 | 58,928,000 | 51,260,000 | 46,924,000 | 46,919,000 | 48,548 | 41,074 | 42,312 | 38,930 | 38,909 | 41,361 |
commitments and contingencies—note 7 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
equity: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
preferred stock, 0.001 par value... | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
common stock, 0.001 par value... | 38,000 | 38,000 | 38,000 | 38,000 | 38,000 | 38,000 | 38,000 | 38,000 | 38,000 | 38,000 | 38,000 | 38,000 | 38,000 | 38,000 | 38,000 | 38,000 | 38,000 | 38,000 | 38,000 | 37,000 | 37,000 | 37,000 | 37,000 | 37,000 | 36,000 | 36,000 | 36,000 | 36,000 | 36,000 | 35,000 | 35,000 | 36,000 | 36,000 | 35,000 | 35,000 | 35,000 | 35,000 | 35,000 | 35,000 | 35,000 | 35,000 | 35,000 | 35,000 | 34,000 | 34,000 | 33,000 | 33,000 | 33,000 | 33,000 | 32,000 | 32,000 | 32,000 | 31,000 | 31,000 | 30,000 | 30,000 | 30,000 | 30,000 | 29,000 | 29,000 | 29,000 | 29,000 | 28,000 | 28,000 | 28,000 | 27,000 | 27,000 | 27,000 | 27,000 | 27,000 | 26,000 | 26,000 | 26,000 | 26,000 | 26,000 | ||||||||||||||||
additional paid-in capital | 833,099,000 | 825,138,000 | 818,201,000 | 809,655,000 | 803,361,000 | 795,063,000 | 787,177,000 | 776,880,000 | 768,789,000 | 758,669,000 | 755,063,000 | 750,914,000 | 743,276,000 | 736,536,000 | 728,118,000 | 720,875,000 | 714,334,000 | 707,006,000 | 698,287,000 | 690,099,000 | 665,580,000 | 656,266,000 | 645,256,000 | 634,854,000 | 623,309,000 | 613,714,000 | 603,666,000 | 592,539,000 | 585,137,000 | 575,926,000 | 568,780,000 | 561,380,000 | 555,029,000 | 544,428,000 | 537,472,000 | 531,112,000 | 523,583,000 | 510,881,000 | 504,290,000 | 495,827,000 | 490,474,000 | 486,267,000 | 481,762,000 | 477,115,000 | 473,634,000 | 470,851,000 | 467,890,000 | 462,962,000 | 458,475,000 | 456,046,000 | 450,792,000 | 446,233,000 | 441,479,000 | 437,024,000 | 432,390,000 | 428,400,000 | 422,273,000 | 416,425,000 | 407,156,000 | 398,133,000 | 387,377,000 | 374,981,000 | 363,670,000 | 351,582,000 | 344,446,000 | 335,111,000 | 326,120,000 | 318,957,000 | 310,017,000 | 302,871,000 | 297,802,000 | 291,706,000 | 287,199,000 | 282,638,000 | 279,553,000 | 158,342,000 | 153,007,000 | 149,109,000 | 146,684,000 | 143,959,000 | 138,751,000 | 135,696,000 | 132,032,000 | 130,685,000 | 58,980,000 | 57,425 | 55,465 | 32,807 | 30,951 | 30,424 | 29,439 |
treasury stock | -480,859,000 | -477,718,000 | -474,854,000 | -473,466,000 | -472,821,000 | -469,243,000 | -468,626,000 | -465,613,000 | -464,688,000 | -462,508,000 | -461,200,000 | -461,168,000 | -457,981,000 | -440,550,000 | -435,868,000 | -420,665,000 | -400,110,000 | -398,752,000 | -319,092,000 | -318,771,000 | -257,625,000 | -255,291,000 | -251,241,000 | -251,070,000 | -246,175,000 | -244,373,000 | -241,685,000 | -240,536,000 | -237,947,000 | -55,019,000 | -53,713,000 | -53,228,000 | -52,500,000 | -47,531,000 | -46,774,000 | -46,253,000 | -45,829,000 | -39,529,000 | -26,966,000 | -22,029,000 | -22,026,000 | -19,860,000 | -19,860,000 | -19,483,000 | -19,464,000 | -18,191,000 | -18,176,000 | -18,080,000 | -18,056,000 | -17,119,000 | -17,116,000 | -17,034,000 | -17,014,000 | -16,044,000 | -15,770,000 | -15,762,000 | -15,702,000 | -14,194,000 | -14,022,000 | -14,008,000 | -2,156,000 | -791,000 | -735,000 | -735,000 | -681,000 | -649,000 | -617,000 | -515,000 | -516,000 | -437,000 | -437,000 | -437,000 | -437,000 | -403,000 | -379,000 | -52,000 | -52,000 | -25,000 | -25,000 | -25,000 | -25,000 | -25,000 | -25,000 | -25,000 | -25,000 | -25 | -25 | -25 | -25 | -25 | -25 |
retained earnings | 880,252,000 | 852,168,000 | 791,156,000 | 811,537,000 | 794,626,000 | 762,325,000 | 747,925,000 | 728,603,000 | 702,643,000 | 782,918,000 | 757,672,000 | 725,955,000 | 700,313,000 | 670,734,000 | 639,063,000 | 605,016,000 | 560,010,000 | 479,861,000 | 429,991,000 | 384,840,000 | 312,859,000 | 278,185,000 | 246,383,000 | 218,728,000 | 184,596,000 | 150,854,000 | 119,550,000 | 92,089,000 | 60,712,000 | 27,363,000 | 204,000 | 4,053,000 | -14,967,000 | -30,545,000 | -39,462,000 | -50,897,000 | -61,593,000 | -67,806,000 | -80,717,000 | -89,157,000 | -99,794,000 | -64,785,000 | -73,920,000 | -82,359,000 | -89,978,000 | -77,561,000 | -67,932,000 | 23,136,000 | 21,296,000 | 18,617,000 | 125,429,000 | 115,507,000 | 107,625,000 | 102,205,000 | 97,891,000 | 521,612,000 | 499,957,000 | 484,669,000 | 462,571,000 | 440,937,000 | 408,735,000 | 372,089,000 | 334,296,000 | 298,357,000 | 263,274,000 | 236,252,000 | 209,911,000 | 186,418,000 | 166,034,000 | 149,570,000 | 132,855,000 | 112,639,000 | 97,722,000 | 84,807,000 | 73,448,000 | 62,889,000 | 53,836,000 | 46,552,000 | 39,251,000 | 31,491,000 | 23,561,000 | 16,451,000 | 10,315,000 | 5,129,000 | 168 | -11,311 | -12,460 | ||||
total amedisys, inc. stockholders’ equity | 1,232,530,000 | 1,199,626,000 | 1,134,541,000 | 1,147,764,000 | 1,125,204,000 | 1,088,183,000 | 1,066,514,000 | 1,039,908,000 | 1,006,782,000 | 1,079,117,000 | 1,051,573,000 | 1,015,739,000 | 985,646,000 | 966,758,000 | 931,351,000 | 905,264,000 | 874,272,000 | 788,153,000 | 809,224,000 | 756,205,000 | 720,851,000 | 679,197,000 | 640,450,000 | 602,564,000 | 561,781,000 | 520,246,000 | 481,582,000 | 444,143,000 | 407,953,000 | 548,320,000 | 515,321,000 | 512,256,000 | 492,075,000 | 481,980,000 | 460,203,000 | 445,447,000 | 426,907,000 | 409,809,000 | 409,568,000 | 393,131,000 | 379,341,000 | 366,663,000 | 397,167,000 | 383,761,000 | 371,860,000 | 362,730,000 | 372,201,000 | 376,998,000 | 463,603,000 | 460,270,000 | 452,340,000 | 554,675,000 | 540,018,000 | 528,651,000 | 518,868,000 | 928,228,000 | 902,233,000 | 877,857,000 | 846,715,000 | 826,189,000 | 783,062,000 | 735,166,000 | 685,135,000 | 641,969,000 | |||||||||||||||||||||||||||
noncontrolling interests | 42,373,000 | 45,448,000 | 45,424,000 | 52,675,000 | 53,682,000 | 54,471,000 | 53,269,000 | 53,610,000 | 53,975,000 | 54,231,000 | 55,000,000 | 53,871,000 | 53,349,000 | 53,894,000 | 44,972,000 | 43,537,000 | 1,615,000 | 1,421,000 | 1,517,000 | 1,538,000 | 1,408,000 | 947,000 | 1,063,000 | 901,000 | 1,161,000 | 954,000 | 1,051,000 | 1,353,000 | 1,108,000 | 1,238,000 | 1,105,000 | 963,000 | 986,000 | 966,000 | 939,000 | 931,000 | 918,000 | 970,000 | 868,000 | 843,000 | 709,000 | 772,000 | 595,000 | -660,000 | -818,000 | 185,000 | 278,000 | 794,000 | 1,427,000 | 1,513,000 | 1,893,000 | 17,305,000 | 1,302,000 | 1,323,000 | 1,280,000 | 1,407,000 | 1,752,000 | 1,894,000 | 1,858,000 | 1,506,000 | 1,332,000 | 1,353,000 | 1,169,000 | 1,013,000 | 873,000 | 808,000 | |||||||||||||||||||||||||
total equity | 1,274,903,000 | 1,245,074,000 | 1,179,965,000 | 1,200,439,000 | 1,178,886,000 | 1,142,654,000 | 1,119,783,000 | 1,093,518,000 | 1,060,757,000 | 1,133,348,000 | 1,106,573,000 | 1,069,610,000 | 1,038,995,000 | 1,020,652,000 | 976,323,000 | 948,801,000 | 875,887,000 | 789,574,000 | 810,741,000 | 757,743,000 | 722,259,000 | 680,144,000 | 641,513,000 | 603,465,000 | 562,942,000 | 521,200,000 | 482,633,000 | 445,496,000 | 409,061,000 | 549,558,000 | 516,426,000 | 513,219,000 | 493,061,000 | 482,946,000 | 461,142,000 | 446,378,000 | 427,825,000 | 410,779,000 | 410,436,000 | 393,974,000 | 380,050,000 | 367,435,000 | 397,762,000 | 383,101,000 | 371,042,000 | 362,915,000 | 372,479,000 | 377,792,000 | 465,030,000 | 461,783,000 | 454,233,000 | 571,980,000 | 541,320,000 | 529,974,000 | 520,148,000 | 511,981,000 | 929,980,000 | 904,127,000 | 879,715,000 | 848,221,000 | 827,521,000 | 784,415,000 | 736,335,000 | 686,148,000 | 642,842,000 | 598,102,000 | |||||||||||||||||||||||||
total liabilities and equity | 2,215,385,000 | 2,184,574,000 | 2,138,714,000 | 2,139,114,000 | 2,117,368,000 | 2,089,871,000 | 2,060,170,000 | 2,027,417,000 | 1,982,402,000 | 1,946,959,000 | 1,976,245,000 | 1,982,127,000 | 2,000,986,000 | 1,908,392,000 | 1,856,968,000 | 1,937,645,000 | 1,599,563,000 | 1,573,209,000 | 1,567,198,000 | 1,602,720,000 | 1,645,488,000 | 1,440,084,000 | 1,262,745,000 | 1,212,380,000 | 1,205,862,000 | 1,184,239,000 | 717,118,000 | 725,892,000 | 753,324,000 | 842,288,000 | 813,482,000 | 799,529,000 | 805,873,000 | 756,628,000 | 734,029,000 | 721,732,000 | 711,102,000 | 705,645,000 | 685,085,000 | 666,436,000 | 645,433,000 | 623,327,000 | 669,742,000 | 682,213,000 | 710,296,000 | 727,390,000 | 726,406,000 | 754,569,000 | 700,253,000 | 712,317,000 | 730,595,000 | 875,724,000 | 858,299,000 | 855,380,000 | 858,285,000 | 846,776,000 | 1,340,647,000 | 1,327,560,000 | 1,299,825,000 | 1,263,922,000 | 1,269,220,000 | 1,222,445,000 | 1,172,351,000 | 1,130,940,000 | 1,083,398,000 | 1,086,401,000 | |||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 19,949 and 18,787 | 80,199,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
restricted cash | 7,475,000 | 12,470,000 | 12,413,000 | 15,904,000 | 15,784,000 | 19,664,000 | 13,593,000 | 13,504,000 | 22,198,000 | 3,075,000 | 3,075,000 | 3,750,000 | 1,000,000 | 1,000,000 | 1,549,000 | 2,549,000 | 3,049,000 | 3,056,000 | 66,196,000 | 5,933,000 | 5,913,000 | 5,921,000 | 4,797,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 18,787 and 14,008 | 81,155,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
commitments and contingencies – note 11 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 17,603 and 14,008 | 99,698,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 16,259 and 14,008 | 100,832,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 15,128 and 14,008 | 101,778,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 14,008 and 14,604 | 102,675,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
commitments and contingencies – note 12 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 12,838 and 14,604 | 103,634,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
commitments and contingencies—note 6 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 17,714 and 14,604 | 104,744,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 16,071 and 14,604 | 99,929,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 14,604 and 19,900 | 101,167,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
deferred income tax assets | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 11,891 and 19,900 | 103,678,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 9,109 and 19,900 | 106,189,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 18,590 and 19,900 | 106,534,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 19,900 and 22,973 | 111,190,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
deferred income taxes | 289,000 | 10,111,000 | 25,271,000 | 40,576,000 | 47,987,000 | 24,189,000 | 25,463,000 | 20,199,000 | 21,427,000 | 17,568,000 | 30,213,000 | 32,525,000 | 35,794,000 | 41,149,000 | 46,919,000 | 53,119,000 | 56,064,000 | 91,160,000 | 100,806,000 | 98,943,000 | 107,940,000 | 113,797,000 | 121,014,000 | 121,367,000 | 125,245,000 | 1,953,000 | 140,485,000 | 146,565,000 | 10,153,000 | 10,712,000 | 57,325,000 | 55,329,000 | 57,008,000 | 61,516,000 | 54,276,000 | 52,286,000 | 36,697,000 | 34,039,000 | 30,821,000 | 29,399,000 | 24,114,000 | 17,907,000 | 16,785,000 | 11,548,000 | 5,852,000 | 1,074,000 | 13,329,000 | 18,495,000 | 13,221,000 | 12,839,000 | 12,057,000 | 10,781,000 | 8,499,000 | 2,680,000 | 3,421,000 | 3,556,000 | 3,671,000 | 8,008,000 | 7,711,000 | 831 | 1,650 | 2,424 | 2,376 | 2,080 | 1,803 | ||||||||||||||||||||||||||
provider relief fund advance | 58,535,000 | 58,328,000 | 55,000,000 | 60,000,000 | 60,000,000 | 70,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 20,309 and 22,973 | 118,084,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 15,842 and 22,973 | 66,432,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 12,738 and 22,973 | 69,764,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 22,973 and 7,044 | 74,183,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accumulated other comprehensive income | 15,000 | 15,000 | 15,000 | 15,000 | 15,000 | 15,000 | 15,000 | 15,000 | 15,000 | 15,000 | 15,000 | 15,000 | 15,000 | 15,000 | 15,000 | 15,000 | 15,000 | 15,000 | 15,000 | 15,000 | 15,000 | 15,000 | 15,000 | 15,000 | 15,000 | 15,000 | 15,000 | 15,000 | 15,000 | 15,000 | 15,000 | 15,000 | 13,000 | 15,000 | 15,000 | 15,000 | 25,000 | -10,000 | 2,000 | 108,000 | 114,000 | -447,000 | -92,000 | 12,000 | -62,000 | 10,000 | 16,000 | ||||||||||||||||||||||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 17,165 and 7,044 | 84,143,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
commitments and contingencies—note 5 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 12,649 and 7,044 | 81,813,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 9,341 and 7,044 | 68,251,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 7,044 and 693 | 64,748,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
commitments and contingencies – note 10 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 36,799 and 33,050 | 66,468,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 35,402 and 33,050 | 61,966,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 33,166 and 33,050 | 62,801,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 33,050 and 30,610 | 44,132,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
commitments and contingencies – note 9 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 32,443 and 30,610 | 44,309,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 31,864 and 30,610 | 44,888,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 31,288 and 30,610 | 45,382,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 20,866, and 17,716 | 201,196,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 30,610 and 27,864 | 46,061,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 19,933 and 17,716 | 177,402,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 29,932 and 27,864 | 44,845,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 17,865 and 17,716 | 173,388,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 29,254 and 27,864 | 45,523,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accrued charge related to securities class action lawsuit settlement | 43,750,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
commitments and contingencies - note 5 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
retained deficit | -10,505,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 19,249 and 17,716 | 172,707,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 28,557 and 27,864 | 46,220,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 17,716, and 16,526 | 166,056,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 27,864 and 25,386 | 46,755,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 16,710 and 16,526 | 162,500,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 27,180 and 25,386 | 47,249,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 15,950 and 16,526 | 152,213,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 26,525 and 25,386 | 47,728,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 16,751 and 16,526 | 153,860,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 25,885 and 25,386 | 43,548,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 16,526, and 14,317 | 125,010,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 25,386 and 25,374 | 44,047,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
current portion of deferred income taxes | 3,329,000 | 2,029,000 | 2,385,000 | 3,169,000 | 3,395,000 | 5,609,000 | 9,249,000 | 11,071,000 | 10,193,000 | 11,748,000 | 8,659,000 | 10,408,000 | 12,694,000 | 14,285,000 | 4,247,000 | 12,679,000 | 11,446,000 | 11,245,000 | 6,661,000 | 6,344,000 | 3,453,000 | 4,663,000 | 7,529,000 | 11,155,000 | 6,771,000 | 13,344,000 | 9,238,000 | 8,280,000 | 11,630,000 | 7,653,000 | 4,473,000 | 3,180,000 | 4,173,000 | 853,000 | 863,000 | 1,353,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 14,753 and 14,317 | 121,744,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
assets held for sale | 19,650,000 | 18,000 | 60,000 | 1,348,000 | 1,550,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 25,379 and 25,374 | 33,150,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
commitments and contingencies - note 6 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 14,228, and 14,317 | 110,454,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 25,374 | 33,193,000 | 33,193,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 14,845, and 14,317 | 110,651,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 14,317, and 14,231 | 99,325,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 25,374 and 25,133 | 33,193,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accrued charge related to u.s. department of justice settlement | 35,000,000 | 35,000,000 | 150,000,000 | 150,000,000 | 150,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 15,640 and 14,231 | 102,859,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 25,370 and 25,133 | 34,096,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 14,956 and 14,231 | 110,934,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 25,354 and 25,133 | 34,112,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 14,131 and 14,231 | 115,350,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 25,279 and 25,133 | 34,336,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 14,231, and 20,994 | 111,133,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 25,133 and 23,457 | 36,690,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 15,601 and 20,994 | 111,149,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 24,926 and 23,457 | 42,332,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
deferred tax asset | 83,123,000 | 85,256,000 | 91,808,000 | 92,804,000 | 54,512,000 | 59,498,000 | 65,674,000 | 68,649,000 | 77,173,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 17,610 and 20,994 | 124,766,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 24,560 and 23,457 | 43,109,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 18,991, and 20,994 | 144,659,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 24,119 and 23,457 | 46,792,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
commitments and contingencies—note 4 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 20,994, and 17,438 | 169,172,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 23,457 and 20,611 | 47,050,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
commitments and contingencies—note 10 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 20,447, and 17,438 | 163,461,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 22,745 and 20,611 | 51,959,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 19,603, and 17,438 | 163,161,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 22,024 and 20,611 | 49,335,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
commitments and contingencies - note 7 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 18,607, and 17,438 | 161,834,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 21,314 and 20,611 | 49,364,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 17,438, and 20,977 | 148,061,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 20,611 and 17,135 | 50,067,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 18,110 and 20,977 | 151,208,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 19,875 and 17,135 | 52,259,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total amedisys, inc. stockholders' equity | 510,574,000 | 597,294,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 18,162 and 20,977 | 153,273,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 19,130 and 17,135 | 62,331,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 19,125 and 20,977 | 141,923,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 18,280 and 17,135 | 52,248,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 20,977 and 26,371 | 141,549,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 17,135 and 11,826 | 53,393,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
obligations due medicare | 4,618,000 | 4,618,000 | 4,618,000 | 4,618,000 | 4,618,000 | 4,618,000 | 4,618,000 | 4,631,000 | 4,631,000 | 4,631,000 | 4,631,000 | 3,185,000 | 2,811,000 | 2,811,000 | 5,927,000 | 5,927,000 | 6,139,000 | 6,139,000 | 7,873,000 | 10,546,000 | 10,551,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
commitments and contingencies—note 9 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 23,036 and 26,371 | 136,450,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 15,972 and 11,826 | 55,900,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 24,523 and 26,371 | 151,855,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 14,792 and 11,824 | 57,732,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 25,806 and 26,371 | 150,572,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 13,337 and 11,824 | 59,093,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 26,371 and 27,052 | 150,269,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 11,824 and 7,944 | 57,608,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
commitments and contingencies — note 9 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 28,352 and 27,052 | 141,011,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 10,648 and 7,944 | 57,361,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accumulated other comprehensive loss | -36,000 | -181,000 | -469,000 | -3,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 30,806 and 27,052 | 154,279,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 9,487 and 7,944 | 57,332,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 28,732 and 27,052 | 154,368,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 8,526 and 7,944 | 50,791,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 27,052 and 12,968 | 175,698,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 7,944 and 6,261 | 42,388,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
liabilities and stockholders’ equity | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
minority interests | 783,000 | 778,000 | 807,000 | 805,000 | 849,000 | 831,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
stockholders’ equity: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total stockholders’ equity | 561,335,000 | 528,288,000 | 495,958,000 | 468,433,000 | 446,971,000 | 424,147,000 | 399,443,000 | 379,983,000 | 364,007,000 | 231,754,000 | 215,860,000 | 202,936,000 | 192,599,000 | 182,446,000 | 169,570,000 | 158,798,000 | 148,473,000 | 140,990,000 | 64,096,000 | 57,580 | 51,399 | 25,376 | 21,139 | 16,963 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total liabilities and stockholders’ equity | 1,070,194,000 | 1,050,723,000 | 1,022,450,000 | 1,037,747,000 | 587,111,000 | 564,727,000 | 518,671,000 | 483,115,000 | 463,756,000 | 370,188,000 | 347,680,000 | 339,511,000 | 339,997,000 | 330,605,000 | 232,919,000 | 217,726,000 | 199,733,000 | 187,914,000 | 111,015,000 | 106,128 | 92,473 | 67,688 | 60,069 | 58,324 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 19,967 and 12,968 at september 30, 2008 and december 31, 2007, respectively | 179,768,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 7,700 and 6,261 at september 30, 2008 and december 31, 2007, respectively | 44,480,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 15,957 and 12,968 at june 30, 2008 and december 31, 2007, respectively | 161,864,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible assets | 44,608,000 | 27,888,000 | 14,301,000 | 13,891,000 | 13,661,000 | 12,741,000 | 12,837,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 17,643 and 12,968 at march 31, 2008 and december 31, 2007, respectively | 144,066,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
long-term obligations, less current portions | 2,555,000 | 36,513,000 | 39,217,000 | 41,151,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 9,870 and 12,387 at december 31, 2006 and 2005, respectively | 74,929,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 4,899 and 3,108 at december 31, 2006 and 2005, respectively | 12,733,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
unearned compensation | -628,000 | -755,000 | -663,000 | -449,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
preferred stock, .001 par value... | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
common stock, .001 par value... | 16,000 | 16,000 | 16,000 | 16,000 | 16,000 | 16,000 | 15,000 | 15,000 | 15,000 | 12,000 | 12 | 10 | 10 | 9 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 7,626 at june 30, 2006 and 12,387 at december 31, 2005 | 63,814,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 4,169 at june 30, 2006 and 3,108 at december 31, 2005 | 14,199,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 10,615 at march 31, 2006 and 12,387 at december 31, 2005 | 67,402,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 3,722 march 31, 2006 and 3,108 at december 31, 2005 | 11,417,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
short-term revolving line of credit | 10,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
short-term investments | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 12,387 and 3,751 at december 31, 2005 and 2004 | 68,139,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible assets, net of accumulated amortization at december 31, 2005 of 3,108 and 1,177 at december 31, 2004 | 11,447,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
current portion of long term obligations | 10,144,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
long-term obligations | 43,063,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other long-term liabilities | 824,000 | 826,000 | 826,000 | 826,000 | 826,000 | 826,000 | 1,213,000 | 1,213 | 1,213 | 1,212 | 826 | 826 | 827 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
assets: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 11,270 at september 30, 2005 and 3,751 at december 31, 2004 | 59,212,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
inventory and other current assets | 5,827,000 | 3,230,000 | 2,838,000 | 3,377,000 | 1,238,000 | 1,123,000 | 1,269 | 1,879 | 955 | 722 | 1,092 | 857 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 2,756 at september 30, 2005 and 1,177 at december 31, 2004 | 13,981,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
liabilities and stockholders’ equity: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accrued expenses: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
payroll and payroll taxes | 27,887,000 | 19,924,000 | 14,920,000 | 11,914,000 | 12,650,000 | 13,536,000 | 10,639 | 9,163 | 8,755 | 7,394 | 6,437 | 6,504 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
insurance | 9,539,000 | 5,325,000 | 5,438,000 | 4,663,000 | 2,725,000 | 2,908,000 | 1,990 | 2,336 | 2,265 | 2,309 | 2,112 | 2,171 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income taxes | 4,957,000 | 1,359,000 | 2,619,000 | 271,000 | 837,000 | 1,400,000 | 735 | 575 | 641 | 457 | 458 | 297 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
legal settlements | 1,739,000 | 1,950,000 | 2,013,000 | 1,375,000 | 1,367,000 | 1,337 | 1,248 | 1,292 | 2,035 | 2,181 | 1,887 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other | 11,716,000 | 5,713,000 | 4,955,000 | 3,822,000 | 3,806,000 | 3,919,000 | 7,985 | 2,818 | 3,491 | 3,148 | 2,435 | 2,439 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
current portion of long-term debt | 9,301,000 | 3,433,000 | 3,396,000 | 1,689,000 | 3,871,000 | 3,875,000 | 4,175 | 3,974 | 3,970 | 3,615 | 3,970 | 3,903 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
current portion of obligations under capital leases | 223,000 | 228,000 | 250,000 | 423,000 | 435,000 | 456,000 | 653 | 1,217 | 1,773 | 2,274 | 2,561 | 2,476 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
current portion of medicare liabilities | 11,583,000 | 9,119,000 | 9,327,000 | 9,326,000 | 9,350 | 9,347 | 8,433 | 7,795 | 8,617 | 8,948 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
long-term debt | 55,072,000 | 1,928,000 | 2,066,000 | 1,380,000 | 1,657,000 | 921,000 | 1,807 | 2,696 | 2,829 | 2,879 | 3,674 | 4,474 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
obligations under capital leases | 136,000 | 162,000 | 189,000 | 329,000 | 401,000 | 486,000 | 391 | 391 | 396 | 334 | 534 | 1,042 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 4,943 at june 30, 2005 and 3,751 at december 31, 2004 | 36,994,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 1,982 at june 30, 2005 and 1,177 at december 31, 2004 | 7,032,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 4,216 at march 31, 2005 and 3,751 at december 31, 2004 | 24,848,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible assets, net of accumulated amortization of 1,549 at march 31, 2005 and 1,177 at december 31, 2004 | 6,621,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
medicare liabilities | 9,263,000 | 9,358,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 3,751 and 3,008 at december 31, 2004 and 2003 | 24,478,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
intangible assets, net of 1,177 net of accumulated amortization at december 31, 2004 | 4,447,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
legal and other settlements | 1,833,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 3,249 at september 30, 2004 and 3,008 at december 31, 2003 | 18,265,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
goodwill and other assets | 63,565,000 | 57,383,000 | 55,106 | 35,658 | 25,768 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 3,624 at june 30, 2004 and 3,008 at december 31, 2003 | 19,841,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
of 3,554 at march 31, 2004 and 3,008 at december 31, 2003 | 14,893 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
none issued and outstanding | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
12,146,898 and 11,908,146 shares issued at march 31, 2004 and december 31, 2003, respectively | 12 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 3,008 and 1,865 at december 2003 and 2002 | 15,185 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
long-term medicare liabilities | 3,078 | 3,444 | 3,328 | 3,898 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
accumulated deficit | -4,053 | -7,416 | -9,797 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 2,641 at september 30, 2003 and 1,865 at december 31, 2002 | 11,567 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 2,192 at june 30, 2003 and 1,865 at december 31, 2002 | 9,424 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 2,309 in march 2003 and 1,865 in december 2002 | 10,227 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
stockholder’s equity: | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
common stock .001 par value... | 9 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total stockholder’s equity | 19,097 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
total liabilities and stockholder’s equity | 58,006 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable, net of allowance for doubtful accounts of 1,865 and 3,125 at december 2002 and 2001 | 13,467 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
notes payable | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
minority interest in consolidated subsidiaries |
Cashflow Statements:
Quarterly
Annual
| Unit: USD | 2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 | 2022-09-30 | 2022-06-30 | 2022-03-31 | 2021-09-30 | 2021-06-30 | 2021-03-31 | 2020-09-30 | 2020-06-30 | 2020-03-31 | 2019-09-30 | 2019-06-30 | 2019-03-31 | 2018-09-30 | 2018-06-30 | 2018-03-31 | 2017-09-30 | 2017-06-30 | 2017-03-31 | 2016-09-30 | 2016-06-30 | 2016-03-31 | 2015-09-30 | 2015-06-30 | 2015-03-31 | 2014-09-30 | 2014-06-30 | 2014-03-31 | 2013-09-30 | 2013-06-30 | 2013-03-31 | 2012-09-30 | 2012-06-30 | 2012-03-31 | 2011-09-30 | 2011-06-30 | 2011-03-31 | 2010-09-30 | 2010-06-30 | 2010-03-31 | 2009-09-30 | 2009-06-30 | 2008-09-30 | 2008-06-30 | 2008-03-31 | 2007-09-30 | 2007-06-30 | 2007-03-31 | 2006-09-30 | 2006-06-30 | 2006-03-31 | 2005-12-31 | 2005-09-30 | 2005-06-30 | 2005-03-31 | 2004-12-31 | 2004-09-30 | 2004-06-30 | 2004-03-31 | 2003-12-31 | 2003-09-30 | 2003-06-30 | 2003-03-31 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
cash flows from operating activities: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net income | 90,873,000 | 61,821,000 | 63,681,000 | 47,167,000 | 14,594,000 | -29,956,000 | -55,572,000 | 24,909,000 | 86,153,000 | 60,750,000 | 31,713,000 | 176,156,000 | 130,911,000 | 50,292,000 | 139,604,000 | 67,193,000 | 32,046,000 | 99,938,000 | 65,613,000 | 31,573,000 | 92,409,000 | 60,861,000 | 27,320,000 | 34,389,000 | 19,728,000 | 15,199,000 | 28,659,000 | 17,158,000 | 6,315,000 | -15,384,000 | 3,758,000 | -4,839,000 | -12,510,000 | -87,797,000 | 3,980,000 | 2,133,000 | 23,424,000 | 13,429,000 | 5,463,000 | -386,662,000 | 37,035,000 | 15,324,000 | 91,004,000 | 69,196,000 | 36,830,000 | 98,184,000 | 62,160,000 | 60,341,000 | 36,848,000 | 16,464,000 | 48,398,000 | 28,182,000 | 13,265,000 | 26,896,000 | 16,337,000 | 7,284,000 | 7,302,000 | 7,760,000 | 7,930,000 | 7,110,000 | 6,136,000 | 5,186,000 | 9,177,779 | 4,221 | 3,363 | 2,381 | 1,514 | 1,149 | ||
adjustments to reconcile net income to net cash from operating activities: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
depreciation and amortization | 13,488,000 | 6,787,000 | 19,331,000 | 12,496,000 | 6,138,000 | 17,956,000 | 11,893,000 | 5,694,000 | 19,705,000 | 14,228,000 | 8,008,000 | 21,763,000 | 14,276,000 | 7,555,000 | 19,955,000 | 11,672,000 | 5,338,000 | 12,440,000 | 8,074,000 | 2,895,000 | 9,882,000 | 6,718,000 | 3,593,000 | 13,139,000 | 8,954,000 | 4,417,000 | 14,662,000 | 9,448,000 | 4,473,000 | 15,798,000 | 11,152,000 | 6,537,000 | 22,149,000 | 15,634,000 | 7,936,000 | 28,730,000 | 19,679,000 | 10,123,000 | 30,046,000 | 20,071,000 | 10,166,000 | 28,907,000 | 19,081,000 | 9,355,000 | 25,297,000 | 16,465,000 | 8,186,000 | 20,682,000 | 13,201,000 | 15,728,000 | 9,843,000 | 4,424,000 | 9,624,000 | 5,771,000 | 2,741,000 | 7,337,000 | 4,850,000 | 2,373,000 | 1,988,000 | 2,123,000 | 1,530,000 | 1,332,000 | 1,092,000 | 1,229,000 | 762 | 740 | ||||
non-cash compensation | 14,749,000 | 6,844,000 | 22,390,000 | 16,184,000 | 7,886,000 | 19,624,000 | 12,381,000 | 3,273,000 | 15,990,000 | 12,495,000 | 7,347,000 | 17,860,000 | 13,463,000 | 7,307,000 | 19,758,000 | 12,634,000 | 5,909,000 | 18,451,000 | 12,153,000 | 6,615,000 | 12,653,000 | 7,811,000 | 4,044,000 | 11,788,000 | 8,230,000 | 3,874,000 | 12,556,000 | 7,806,000 | 4,070,000 | 7,637,000 | 4,577,000 | 2,384,000 | 3,197,000 | 1,500,000 | 431,000 | 4,933,000 | 3,280,000 | 2,056,000 | 6,065,000 | 4,780,000 | 2,482,000 | 8,265,000 | 5,115,000 | 1,910,000 | 8,317,000 | 5,681,000 | 2,513,000 | 5,740,000 | 4,920,000 | |||||||||||||||||||||
amortization and impairment of operating lease right of use assets | 17,395,000 | 8,645,000 | 25,720,000 | 17,100,000 | 8,566,000 | 25,427,000 | 16,971,000 | 8,622,000 | 34,782,000 | 22,463,000 | 10,096,000 | 30,181,000 | 19,702,000 | 9,850,000 | 29,149,000 | 18,558,000 | 9,058,000 | 27,014,000 | 17,495,000 | 8,345,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
gain on disposal of property and equipment | -45,000 | -64,000 | -94,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
gain on equity method investment | -48,093,000 | -48,093,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
gain on termination of joint venture | -3,568,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
deferred income taxes | 16,395,000 | 9,981,000 | 7,382,000 | 6,577,000 | 2,594,000 | 15,417,000 | 8,104,000 | 2,772,000 | 19,031,000 | 6,003,000 | 3,205,000 | 34,729,000 | 22,716,000 | 7,411,000 | -2,762,000 | -4,036,000 | 1,228,000 | 17,798,000 | 5,875,000 | 3,269,000 | 14,916,000 | 9,145,000 | 2,945,000 | 17,228,000 | 7,582,000 | 9,445,000 | 18,689,000 | 11,362,000 | 4,038,000 | -9,547,000 | -14,788,000 | -22,165,000 | 6,357,000 | -3,017,000 | -7,799,000 | -53,611,000 | 2,959,000 | -1,287,000 | 11,637,000 | 8,474,000 | 1,421,000 | -133,623,000 | 3,708,000 | 399,000 | 300,000 | 6,074,000 | 1,623,000 | 11,677,000 | 5,154,000 | 17,939,000 | 6,386,000 | 1,324,000 | 3,755,000 | -1,212,000 | -2,953,000 | 8,745,000 | -253,000 | 6,971,000 | -305,000 | 287,000 | 472,000 | 2,793,000 | 1,052,000 | 3,149,673 | 1,327 | 1,764 | 1,327 | 869 | 660 | |
equity in earnings from equity method investments | -3,435,000 | -1,794,000 | -4,316,000 | -2,425,000 | -910,000 | -3,932,000 | -2,488,000 | -1,118,000 | -2,399,000 | -964,000 | -477,000 | -4,120,000 | -4,932,000 | -1,216,000 | -6,461,000 | -4,836,000 | -3,149,000 | -2,249,000 | -3,602,000 | -358,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
amortization of deferred debt issuance costs | 442,000 | 248,000 | 743,000 | 495,000 | 248,000 | 743,000 | 495,000 | 248,000 | 355,000 | 178,000 | 555,000 | 370,000 | 185,000 | 774,000 | 553,000 | 276,000 | 521,000 | 283,000 | 141,000 | 548,000 | 370,000 | 193,000 | 1,182,000 | 788,000 | 394,000 | 1,182,000 | 788,000 | 394,000 | 1,182,000 | 788,000 | 394,000 | 1,182,000 | 788,000 | 813,000 | 419,000 | 25,000 | ||||||||||||||||||||||||||||||||||
return on equity method investments | 3,379,000 | 2,320,000 | 2,160,000 | 718,000 | 170,000 | 4,309,000 | 2,753,000 | 1,787,000 | 3,798,000 | 2,428,000 | 1,710,000 | 4,268,000 | 2,683,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||
impairment | 883,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
changes in operating assets and liabilities: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
patient accounts receivable | 554,000 | -23,564,000 | 11,503,000 | -44,357,000 | -46,806,000 | -32,934,000 | 7,862,000 | -7,476,000 | -18,266,000 | -21,344,000 | -18,618,000 | -17,638,000 | -22,787,000 | -20,448,000 | 6,486,000 | 8,997,000 | -25,459,000 | -39,469,000 | -24,165,000 | -22,333,000 | 6,166,000 | 3,604,000 | 8,260,000 | -28,924,000 | -17,825,000 | -12,493,000 | -46,107,000 | -30,349,000 | -27,689,000 | -31,788,000 | -16,861,000 | -14,302,000 | -5,848,000 | -9,740,000 | -9,185,000 | 45,170,000 | 35,684,000 | 20,545,000 | -31,686,000 | -25,722,000 | -19,686,000 | -5,883,000 | -3,320,000 | -3,536,000 | -250,000 | -10,395,000 | -4,648,000 | 18,155,000 | 9,465,000 | -54,829,000 | ||||||||||||||||||||
other current assets | 3,576,000 | 3,480,000 | 11,242,000 | 3,127,000 | -1,696,000 | -15,434,000 | 1,689,000 | -4,128,000 | -19,929,000 | -4,468,000 | 7,882,000 | -6,219,000 | 3,560,000 | -2,874,000 | -28,217,000 | -3,469,000 | -5,756,000 | -10,194,000 | -8,343,000 | -10,635,000 | -32,000 | -11,680,000 | -6,982,000 | -5,896,000 | -6,892,000 | -3,403,000 | 870,000 | 5,551,000 | 7,845,000 | 12,701,000 | 3,849,000 | -3,677,000 | -1,885,000 | -2,215,000 | -6,337,000 | 1,409,000 | -2,878,000 | -8,420,000 | 2,875,000 | 411,000 | 1,335,000 | 8,960,000 | 10,117,000 | 5,112,000 | 16,006,000 | 11,120,000 | 4,885,000 | 1,415,000 | -2,020,000 | -3,223,000 | ||||||||||||||||||||
operating lease right of use assets | -2,364,000 | -1,186,000 | -3,135,000 | -2,069,000 | -1,042,000 | -2,803,000 | -1,937,000 | -918,000 | -2,323,000 | -1,662,000 | -749,000 | -2,304,000 | -1,524,000 | -762,000 | -2,775,000 | -1,924,000 | -817,000 | -2,622,000 | -1,754,000 | -844,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
other assets | 48,000 | 88,000 | 598,000 | 370,000 | 155,000 | 273,000 | 244,000 | -111,000 | 283,000 | 220,000 | 247,000 | -938,000 | -52,000 | -115,000 | -91,000 | -675,000 | 417,000 | 202,000 | -56,000 | -338,000 | 726,000 | 688,000 | 46,000 | -12,202,000 | -1,148,000 | -990,000 | -11,909,000 | -11,943,000 | -2,775,000 | -803,000 | -1,160,000 | -1,014,000 | 1,554,000 | 1,200,000 | -1,219,000 | -2,069,000 | -800,000 | -517,000 | -483,000 | -545,000 | -39,000 | -4,304,000 | -6,364,000 | -493,000 | -1,934,000 | -2,777,000 | 295,000 | 1,930,000 | 1,775,000 | -211,000 | ||||||||||||||||||||
accounts payable | -9,805,000 | -10,913,000 | 4,167,000 | -1,693,000 | 8,652,000 | -8,839,000 | -4,731,000 | -3,457,000 | 5,886,000 | 4,498,000 | -2,115,000 | -1,192,000 | -6,530,000 | -3,374,000 | -1,627,000 | -6,452,000 | -2,673,000 | -8,145,000 | -9,475,000 | -11,140,000 | -670,000 | 3,623,000 | -1,523,000 | -5,430,000 | 1,093,000 | 93,000 | 7,308,000 | 8,608,000 | 9,098,000 | 8,597,000 | 6,163,000 | 8,156,000 | 668,000 | 414,000 | 3,491,000 | -8,111,000 | -7,963,000 | -945,000 | 194,000 | 1,457,000 | -87,000 | 814,000 | -357,000 | 2,889,000 | 2,907,000 | 5,436,000 | 4,636,000 | 3,572,000 | 1,754,000 | -13,501,000 | ||||||||||||||||||||
accrued expenses | -15,666,000 | -10,658,000 | 12,495,000 | 7,095,000 | 3,029,000 | 10,340,000 | 4,775,000 | 741,000 | -26,790,000 | 29,529,000 | 7,483,000 | -9,363,000 | -1,627,000 | 8,370,000 | 25,594,000 | 27,990,000 | -13,627,000 | 27,903,000 | 29,262,000 | 18,838,000 | 14,758,000 | 4,548,000 | -1,807,000 | 22,584,000 | -2,743,000 | 1,386,000 | -9,100,000 | -2,811,000 | 801,000 | 9,152,000 | 4,189,000 | -5,681,000 | -4,081,000 | 5,958,000 | 9,591,000 | -11,198,000 | -4,293,000 | 1,990,000 | -10,815,000 | -3,976,000 | 2,051,000 | -1,475,000 | 2,398,000 | 17,605,000 | -3,771,000 | 1,571,000 | 7,425,000 | 23,885,000 | 9,489,000 | 36,661,000 | ||||||||||||||||||||
other long-term obligations | -34,000 | -34,000 | -532,000 | -573,000 | -591,000 | -3,156,000 | -3,179,000 | -28,000 | 243,000 | -223,000 | -57,000 | -1,785,000 | -1,736,000 | -808,000 | 38,481,000 | 20,746,000 | 3,060,000 | -231,000 | -181,000 | -144,000 | 2,462,000 | 2,347,000 | 2,348,000 | 201,000 | 607,000 | 576,000 | -150,000 | -464,000 | -521,000 | -286,000 | 552,000 | -71,000 | -2,762,000 | 1,135,000 | 1,250,000 | 3,625,000 | 537,000 | 90,000 | -421,000 | -578,000 | -239,000 | -3,535,000 | -1,374,000 | -1,543,000 | 551,000 | 663,000 | -625,000 | 2,695,000 | 2,509,000 | -1,963,000 | ||||||||||||||||||||
operating lease liabilities | -15,248,000 | -7,625,000 | -22,019,000 | -14,429,000 | -7,532,000 | -23,256,000 | -15,456,000 | -7,960,000 | -30,864,000 | -20,657,000 | -9,187,000 | -27,372,000 | -17,955,000 | -9,014,000 | -25,576,000 | -16,365,000 | -8,132,000 | -24,116,000 | -16,200,000 | -8,139,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
net cash from operating activities | 63,524,000 | -3,687,000 | 151,388,000 | 45,764,000 | -6,541,000 | 76,877,000 | 86,720,000 | 25,961,000 | 92,400,000 | 106,030,000 | 48,621,000 | 183,727,000 | 121,960,000 | 54,002,000 | 223,040,000 | 139,957,000 | 6,035,000 | 126,780,000 | 79,325,000 | 20,059,000 | 159,450,000 | 90,970,000 | 40,317,000 | 73,542,000 | 63,341,000 | 27,097,000 | 33,698,000 | 26,895,000 | 12,244,000 | 87,741,000 | 57,037,000 | 14,483,000 | -70,129,000 | -95,471,000 | -6,342,000 | 93,862,000 | 65,977,000 | 32,416,000 | 56,904,000 | 35,022,000 | 11,871,000 | 104,293,000 | 76,513,000 | 52,554,000 | 172,608,000 | 125,434,000 | 71,037,000 | 218,922,000 | 130,298,000 | 86,834,000 | 57,544,000 | 25,688,000 | 81,762,000 | 55,255,000 | 35,041,000 | 26,388,000 | 14,808,000 | -6,499,000 | 14,547,000 | 15,598,000 | 2,767,000 | 10,628,000 | 5,140,000 | 8,516,000 | 16,045,267 | 9,733 | 5,769 | 3,881 | 6,755 | 5,383 |
capital expenditures | -1,915,000 | -1,215,000 | -5,440,000 | -4,055,000 | -2,670,000 | -3,728,000 | -2,744,000 | -1,350,000 | -4,338,000 | -2,782,000 | -902,000 | -5,187,000 | -2,943,000 | -1,618,000 | -2,995,000 | -1,701,000 | -1,434,000 | -6,337,000 | -2,693,000 | -1,198,000 | -5,684,000 | -1,611,000 | -1,462,000 | -9,074,000 | -7,449,000 | -4,385,000 | -13,502,000 | -9,915,000 | -6,702,000 | -17,969,000 | -16,668,000 | -2,113,000 | -9,882,000 | -9,068,000 | -5,532,000 | -28,983,000 | -19,595,000 | -10,074,000 | -32,198,000 | -20,241,000 | -10,236,000 | -38,573,000 | -26,032,000 | -16,580,000 | -37,535,000 | -23,910,000 | -9,966,000 | -25,998,000 | -15,056,000 | -20,610,000 | -11,627,000 | -5,305,000 | -23,087,000 | -16,447,000 | -7,232,000 | -20,419,000 | -12,608,000 | -4,676,000 | 0 | -3,747,000 | -6,173,000 | -5,518,000 | -1,661,000 | -1,686,000 | -1,883,375 | -625 | -1,044 | -122 | -325 | -298 |
free cash flows | 61,609,000 | -4,902,000 | 145,948,000 | 41,709,000 | -9,211,000 | 73,149,000 | 83,976,000 | 24,611,000 | 88,062,000 | 103,248,000 | 47,719,000 | 178,540,000 | 119,017,000 | 52,384,000 | 220,045,000 | 138,256,000 | 4,601,000 | 120,443,000 | 76,632,000 | 18,861,000 | 153,766,000 | 89,359,000 | 38,855,000 | 64,468,000 | 55,892,000 | 22,712,000 | 20,196,000 | 16,980,000 | 5,542,000 | 69,772,000 | 40,369,000 | 12,370,000 | -80,011,000 | -104,539,000 | -11,874,000 | 64,879,000 | 46,382,000 | 22,342,000 | 24,706,000 | 14,781,000 | 1,635,000 | 65,720,000 | 50,481,000 | 35,974,000 | 135,073,000 | 101,524,000 | 61,071,000 | 192,924,000 | 115,242,000 | 66,224,000 | 45,917,000 | 20,383,000 | 58,675,000 | 38,808,000 | 27,809,000 | 5,969,000 | 2,200,000 | -11,175,000 | 14,547,000 | 11,851,000 | -3,406,000 | 5,110,000 | 3,479,000 | 6,830,000 | 14,161,892 | 9,108 | 4,725 | 3,759 | 6,430 | 5,085 |
cash flows from investing activities: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from the sale of deferred compensation plan assets | 27,000 | 27,000 | 21,000 | 21,000 | 21,000 | 25,000 | 25,000 | 19,000 | 89,000 | 28,000 | 22,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from the sale of property and equipment | 19,000 | 15,000 | 100,000 | 100,000 | 66,000 | 37,000 | 37,000 | 42,000 | 80,000 | 80,000 | 12,000 | 158,000 | 146,000 | 65,000 | 51,000 | 11,000 | 5,000 | 118,000 | 3,000 | 126,000 | 126,000 | 61,000 | 609,000 | 590,000 | 41,000 | 3,000 | 13,000 | 3,000 | 2,000 | 3,091,000 | 16,000 | 16,000 | 50,000 | 50,000 | 49,000 | |||||||||||||||||||||||||||||||||||
purchases of property and equipment | -1,915,000 | -1,215,000 | -5,440,000 | -4,055,000 | -2,670,000 | -3,728,000 | -2,744,000 | -1,350,000 | -4,338,000 | -2,782,000 | -902,000 | -5,187,000 | -2,943,000 | -1,618,000 | -2,995,000 | -1,701,000 | -1,434,000 | -6,337,000 | -2,693,000 | -1,198,000 | -5,684,000 | -1,611,000 | -1,462,000 | -9,074,000 | -7,449,000 | -4,385,000 | -13,502,000 | -9,915,000 | -6,702,000 | -17,969,000 | -16,668,000 | -2,113,000 | -9,882,000 | -9,068,000 | -5,532,000 | -28,983,000 | -19,595,000 | -10,074,000 | -32,198,000 | -20,241,000 | -10,236,000 | -38,573,000 | -26,032,000 | -16,580,000 | -37,535,000 | -23,910,000 | -9,966,000 | -25,998,000 | -15,056,000 | -20,610,000 | -11,627,000 | -5,305,000 | -23,087,000 | -16,447,000 | -7,232,000 | -20,419,000 | -12,608,000 | -4,676,000 | ||||||||||||
investments in technology assets | -426,000 | -201,000 | -619,000 | -409,000 | -223,000 | -6,881,000 | -6,667,000 | -210,000 | -848,000 | -559,000 | -236,000 | -147,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
investment in equity method investee | -196,000 | -196,000 | -637,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash from investing activities | -2,295,000 | -1,374,000 | -7,084,000 | -4,639,000 | -3,068,000 | 37,103,000 | 38,151,000 | 45,896,000 | -92,620,000 | -91,587,000 | -16,079,000 | -269,940,000 | -5,379,000 | -1,557,000 | -285,543,000 | -284,322,000 | -70,755,000 | -351,562,000 | -347,958,000 | -328,912,000 | -12,621,000 | -5,203,000 | -3,245,000 | -32,898,000 | -31,448,000 | -8,175,000 | -45,400,000 | -37,751,000 | -34,154,000 | -19,859,000 | -11,822,000 | -2,068,000 | -9,162,000 | -9,392,000 | -4,920,000 | -35,456,000 | -24,215,000 | -16,825,000 | -40,249,000 | -27,931,000 | -10,053,000 | -168,663,000 | -151,535,000 | -15,946,000 | -41,660,000 | -27,686,000 | -14,366,000 | -64,771,000 | -41,485,000 | -468,840,000 | -459,807,000 | -441,851,000 | -101,543,000 | -50,339,000 | -12,736,000 | -30,681,000 | -21,325,000 | -8,718,000 | 23,796,000 | -125,212,000 | -10,139,000 | -21,146,000 | 63,809,000 | -6,255,000 | -22,588,233 | -14,767 | -1,278 | -6,426 | -325 | -298 |
cash flows from financing activities: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of stock upon exercise of stock options | 149,000 | 88,000 | 100,000 | 75,000 | 1,078,000 | 772,000 | 86,000 | 1,706,000 | 623,000 | 364,000 | 6,070,000 | 2,947,000 | 1,184,000 | 3,388,000 | 1,343,000 | 356,000 | 89,000 | 88,000 | 1,155,000 | 244,000 | 2,138,000 | 1,734,000 | 1,010,000 | |||||||||||||||||||||||||||||||||||||||||||||||
shares withheld to pay taxes on non-cash compensation | -6,005,000 | -2,864,000 | -4,840,000 | -4,195,000 | -617,000 | -4,413,000 | -3,488,000 | -1,308,000 | -7,949,000 | -4,762,000 | -4,682,000 | -16,694,000 | -6,944,000 | -6,774,000 | -54,172,000 | -6,384,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
noncontrolling interest contributions | 1,911,000 | 1,911,000 | 1,764,000 | 1,232,000 | 376,000 | 2,100,000 | 952,000 | 652,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
noncontrolling interest distributions | -1,260,000 | -785,000 | -2,574,000 | -1,964,000 | -756,000 | -1,614,000 | -712,000 | -285,000 | -1,425,000 | -975,000 | -672,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
principal payments of long-term obligations | -19,552,000 | -9,744,000 | -27,730,000 | -18,382,000 | -8,941,000 | -67,113,000 | -60,993,000 | -55,313,000 | -10,126,000 | -6,975,000 | -3,771,000 | -5,893,000 | -5,392,000 | -2,692,000 | -7,360,000 | -4,675,000 | -1,592,000 | -3,820,000 | -2,277,000 | -559,000 | -91,071,000 | -90,475,000 | -2,819,000 | -4,069,000 | -2,500,000 | -1,250,000 | -3,750,000 | -2,500,000 | -1,250,000 | -103,000,000 | -6,000,000 | -3,000,000 | -10,904,000 | -7,627,000 | -3,952,000 | -31,856,000 | -27,904,000 | -23,952,000 | -25,489,000 | -17,038,000 | -8,550,000 | -29,674,000 | -19,576,000 | -9,627,000 | -34,026,000 | -22,583,000 | -12,274,000 | -33,810,000 | -21,708,000 | -85,124,000 | -45,288,000 | -3,155,000 | -3,016,000 | -1,548,000 | -903,000 | -8,180,000 | -5,315,000 | -3,523,000 | ||||||||||||
debt issuance costs | -499,000 | -2,792,000 | -847,000 | -847,000 | -847,000 | -2,433,000 | -2,433,000 | -2,553,000 | -901,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash from financing activities | -27,167,000 | -13,300,000 | -37,717,000 | -22,630,000 | -8,550,000 | -74,097,000 | -67,843,000 | -56,890,000 | -14,089,000 | -11,448,000 | -7,402,000 | 131,064,000 | -107,292,000 | -57,458,000 | 81,466,000 | 228,202,000 | 146,042,000 | 225,310,000 | 262,306,000 | 299,178,000 | -219,182,000 | -146,226,000 | -3,430,000 | -4,727,000 | -2,926,000 | -785,000 | -6,885,000 | -6,678,000 | 2,232,000 | -18,863,000 | -20,046,000 | -17,315,000 | 67,530,000 | 98,785,000 | -3,201,000 | -29,325,000 | -26,189,000 | -23,115,000 | -25,553,000 | -17,937,000 | -8,532,000 | -26,463,000 | -17,141,000 | -8,035,000 | -37,396,000 | -16,206,000 | -9,176,000 | -111,838,000 | -90,762,000 | 331,480,000 | 347,733,000 | 385,209,000 | 2,152,000 | 2,204,000 | 957,000 | -3,083,000 | -2,757,000 | 7,462,000 | -9,861,000 | 58,300,000 | 518,000 | -244,000 | -1,999,000 | 68,641,000 | -951,593 | -407 | 15,224 | -192 | -1,970 | -1,605 |
net increase in cash, cash equivalents and restricted cash | 34,062,000 | 106,587,000 | 18,495,000 | -18,159,000 | 39,883,000 | 57,028,000 | 14,967,000 | -14,309,000 | 2,995,000 | 25,140,000 | 44,851,000 | 9,289,000 | -5,013,000 | 18,963,000 | 83,837,000 | 81,322,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash, cash equivalents and restricted cash at beginning of period | 303,242,000 | 303,242,000 | 138,863,000 | 138,863,000 | 138,863,000 | 54,133,000 | 54,133,000 | 54,133,000 | 45,769,000 | 45,769,000 | 45,769,000 | 83,357,000 | 83,357,000 | 83,357,000 | 96,490,000 | 96,490,000 | 96,490,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
cash, cash equivalents and restricted cash at end of period | 337,304,000 | 284,881,000 | 245,450,000 | 157,358,000 | 120,704,000 | 94,016,000 | 111,161,000 | 69,100,000 | 31,460,000 | 48,764,000 | 70,909,000 | 128,208,000 | 92,646,000 | 78,344,000 | 115,453,000 | 180,327,000 | 177,812,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
supplemental disclosures of cash flow information: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash paid for interest | 12,359,000 | 6,177,000 | 1,011,000 | 4,902,000 | 3,292,000 | 1,755,000 | 7,756,000 | 4,187,000 | 725,000 | 2,989,000 | 2,080,000 | 1,065,000 | 2,188,000 | 1,172,000 | 706,000 | 2,276,000 | 1,359,000 | 648,000 | 5,598,000 | 3,598,000 | 1,827,000 | 4,771,000 | 2,974,000 | 425,000 | 2,384,000 | 2,006,000 | 1,629,000 | 6,896,000 | 3,494,000 | 3,388,000 | 7,094,000 | 3,656,000 | 3,490,000 | 7,949,000 | 4,266,000 | 3,735,000 | 9,885,000 | 5,920,000 | 10,406,000 | 4,072,000 | 710,000 | 260,000 | 194,000 | 91,000 | 3,038,000 | 2,073,000 | 1,051,000 | |||||||||||||||||||||||
cash paid for income taxes, net of refunds received | 25,330,000 | 907,000 | 971,000 | 30,290,000 | 8,153,000 | 5,272,000 | 17,656,000 | 7,849,000 | 404,000 | 11,017,000 | 6,149,000 | 2,813,000 | 315,000 | 284,000 | 284,000 | 758,000 | 825,000 | -7,000 | -12,383,000 | -2,496,000 | -89,000 | 13,000 | 3,235,000 | 3,135,000 | 3,135,000 | 1,620,000 | 1,470,000 | 1,150,000 | 11,273,000 | 6,273,000 | 2,793,000 | 49,870,000 | 31,870,000 | 14,620,000 | 47,135,000 | 27,915,000 | 18,783,000 | 16,848,000 | 8,365,000 | 17,455,000 | 6,724,000 | 777,000 | 2,870,000 | 1,933,000 | 874,000 | |||||||||||||||||||||||||
cash paid for operating lease liabilities | 17,612,000 | 8,811,000 | 9,776,000 | 28,351,000 | 18,289,000 | 8,949,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash paid for finance lease liabilities | 8,302,000 | 4,121,000 | 503,000 | 1,483,000 | 986,000 | 499,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
loss on disposal of property and equipment | -34,000 | -22,000 | -19,000 | 4,000 | 346,000 | 356,000 | -70,000 | 507,000 | 531,000 | 5,000 | 8,000 | 14,000 | -77,000 | 55,000 | 6,000 | -2,000 | -4,000 | 738,000 | 650,000 | 563,000 | -22,000 | 147,000 | -16,000 | 556,000 | 522,000 | 360,000 | 945,000 | 530,000 | 196,000 | 4,174,000 | 2,688,000 | 332,000 | 1,239,000 | 708,000 | 211,000 | 1,066,000 | 848,000 | 505,000 | 1,796,000 | 1,313,000 | 656,000 | 2,314,000 | 2,019,000 | 171,000 | 593,000 | 535,000 | 611,000 | 483,000 | 161,000 | 301,000 | 397,000 | 48,000 | 459,000 | 179,000 | -9,000 | |||||||||||||||
proceeds from the issuance of stock upon exercise of stock options | 93,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net decrease in cash, cash equivalents and restricted cash | -18,361,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
supplemental disclosures of non-cash activity: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
right of use assets obtained in exchange for operating lease liabilities | 7,006,000 | 10,548,000 | 29,876,000 | 18,891,000 | 6,437,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
right of use assets obtained in exchange for finance lease liabilities | 3,158,000 | 177,000 | 822,000 | 487,000 | 254,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
reductions to right of use assets resulting from reductions to operating lease liabilities | 75,000 | 279,000 | 767,000 | 407,000 | 159,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
reductions to right of use assets resulting from reductions to finance lease liabilities | 415,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
gain on deconsolidation of joint venture | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
loss on personal care divestiture | 2,186,000 | 2,186,000 | 2,186,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
merger termination fee | 106,000,000 | 106,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
equity in (earnings) loss from equity method investments | -9,366,000 | -8,114,000 | -123,000 | -1,860,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
changes in operating assets and liabilities, net of impact of acquisitions: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchase of cost method investment | -15,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
return of investment | 150,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from personal care divestiture | 47,787,000 | 47,787,000 | 47,787,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
acquisitions of businesses, net of cash acquired | -350,000 | -350,000 | -350,000 | -71,952,000 | -73,311,000 | -264,872,000 | -2,503,000 | -299,723,000 | -299,723,000 | -69,349,000 | -345,460,000 | -345,414,000 | -327,867,000 | -4,074,000 | -4,074,000 | -2,250,000 | -24,128,000 | -24,128,000 | -4,099,000 | -31,378,000 | -27,634,000 | -27,682,000 | -5,800,000 | -627,000 | -627,000 | -627,000 | -8,744,000 | -8,392,000 | -125,977,000 | -125,977,000 | -3,121,000 | -2,721,000 | -1,969,000 | -31,492,000 | -19,205,000 | -447,082,000 | -447,124,000 | -436,481,000 | -79,154,000 | -31,616,000 | -4,396,000 | |||||||||||||||||||||||||||||
proceeds from issuance of stock to employee stock purchase plan | 816,000 | 2,857,000 | 1,891,000 | 985,000 | 3,022,000 | 1,961,000 | 1,048,000 | 2,600,000 | 1,686,000 | 860,000 | 2,384,000 | 1,534,000 | 782,000 | 1,787,000 | 1,157,000 | 597,000 | 1,798,000 | 1,187,000 | 612,000 | 1,818,000 | 1,207,000 | 638,000 | 1,591,000 | 1,059,000 | 504,000 | 1,875,000 | 1,324,000 | 657,000 | 2,436,000 | 1,695,000 | 837,000 | 2,934,000 | 1,978,000 | 962,000 | 3,961,000 | 2,731,000 | 1,578,000 | 4,690,000 | 3,012,000 | 1,445,000 | 4,081,000 | 2,734,000 | 2,665,000 | 1,688,000 | 774,000 | 1,896,000 | 1,254,000 | 599,000 | 1,465,000 | 834,000 | 295,000 | 564,000 | 247,000 | |||||||||||||||||
proceeds from sale of noncontrolling interest | 3,941,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchase of noncontrolling interest | -800,000 | -800,000 | -800,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from borrowings under revolving line of credit | 23,000,000 | 23,000,000 | 8,000,000 | 484,000,000 | 298,500,000 | 500,700,000 | 389,200,000 | 215,200,000 | 432,000,000 | 424,500,000 | 187,500,000 | 192,500,000 | 184,500,000 | 161,500,000 | 127,500,000 | 127,500,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
repayments of borrowings under revolving line of credit | -23,000,000 | -23,000,000 | -8,000,000 | -465,500,000 | -283,500,000 | -551,700,000 | -410,200,000 | -186,200,000 | -357,000,000 | -259,500,000 | -37,500,000 | -133,000,000 | -92,000,000 | -34,000,000 | -70,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchase of company stock | -17,351,000 | -17,351,000 | -84,879,000 | -74,074,000 | -72,886,000 | -181,402,000 | -181,402,000 | -12,315,000 | -12,315,000 | -12,315,000 | -11,796,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
payment of accrued contingent consideration | -4,572,000 | -4,091,000 | -4,055,000 | -5,714,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
investments in equity method investees | -1,046,000 | -875,000 | -875,000 | -210,000 | -210,000 | -120,000 | -3,477,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of stock under employee stock purchase plan | 2,602,000 | 1,754,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
gain on equity method investments | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
investment impairment | 3,009,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from borrowings under term loan | 290,312,000 | 175,000,000 | 175,000,000 | 175,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
provider relief fund advance | -1,465,000 | -1,672,000 | -5,000,000 | 60,000,000 | 70,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
loss on equity method investments | -31,092,000 | -31,092,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
write-off of other comprehensive income | -15,000 | -15,000 | -15,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
equity in loss (earnings) from equity method investments | 442,000 | 744,000 | 1,403,000 | 5,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
amortization of deferred debt issuance costs/debt discount | 743,000 | 495,000 | 248,000 | 669,000 | 432,000 | 216,000 | 653,000 | 437,000 | 220,000 | 653,000 | 433,000 | 213,000 | 596,000 | 555,000 | 370,000 | 185,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
impairment charge | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from sale of equity method investment | 17,876,000 | 17,876,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other investments | -15,000,000 | -15,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
non-cash 401(k) employer match | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
asset impairment charge | 77,268,000 | 75,193,000 | 75,193,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchase of investment | -436,000 | -436,000 | -256,000 | -750,000 | -432,000 | -2,561,000 | -1,161,000 | -6,227,000 | -6,227,000 | -4,500,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from sale of deferred compensation plan assets | 126,000 | 25,000 | 19,000 | 94,000 | 21,000 | 16,000 | 287,000 | 213,000 | 208,000 | 563,000 | 471,000 | 462,000 | 622,000 | 565,000 | 565,000 | 230,000 | 230,000 | 230,000 | 1,026,000 | 64,000 | 9,000 | 5,000 | 128,000 | 100,000 | 71,000 | 239,000 | 239,000 | 230,000 | 859,000 | 853,000 | 853,000 | 2,425,000 | 2,340,000 | 956,000 | 956,000 | |||||||||||||||||||||||||||||||||||
proceeds from sale of property and equipment | 140,000 | 42,000 | 29,000 | 106,000 | -41,000 | 115,000 | 53,000 | 26,000 | 22,991 | 9 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
noncontrolling interest distribution | -1,253,000 | -794,000 | -518,000 | -672,000 | -372,000 | -360,000 | -910,000 | -457,000 | -366,000 | -530,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
return on equity investment | 1,500,000 | 3,919,000 | 2,744,000 | 2,369,000 | 3,727,000 | 842,000 | 725,000 | 4,373,000 | 2,204,000 | 625,000 | 4,656,000 | 3,416,000 | 150,000 | 1,913,000 | 362,000 | 362,000 | 5,135,000 | 4,638,000 | 645,000 | 1,500,000 | 700,000 | 400,000 | 975,000 | 400,000 | 400,000 | 1,050,000 | 625,000 | 150,000 | 1,088,000 | 540,000 | 240,000 | 1,390,000 | 840,000 | 90,000 | 625,000 | 150,000 | 187,000 | 112,000 | 75,000 | |||||||||||||||||||||||||||||||
loss on sale of equity method investment | 2,980,000 | 2,980,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
non-controlling interest distribution | -350,000 | -28,000 | -216,000 | -90,000 | -42,000 | -284,000 | -200,000 | -300,000 | -300,000 | -163,000 | -93,000 | -105,000 | -105,000 | -568,000 | -198,000 | -185,000 | -185,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
repurchase of noncontrolling interest | -361,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
supplemental disclosures of non-cash financing activity: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
note payable issued for software licenses | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
401(k) employer match | 3,291,000 | 7,545,000 | 4,686,000 | 2,379,000 | 6,934,000 | 4,894,000 | 2,567,000 | 6,547,000 | 4,367,000 | 2,227,000 | 5,134,000 | 3,440,000 | 1,737,000 | 4,544,000 | 3,454,000 | 1,813,000 | 4,682,000 | 3,048,000 | 1,392,000 | 6,200,000 | 4,363,000 | 2,240,000 | 7,575,000 | 5,040,000 | 2,347,000 | 5,845,000 | 3,332,000 | 1,403,000 | 17,536,000 | 11,467,000 | 5,705,000 | 13,827,000 | 9,581,000 | |||||||||||||||||||||||||||||||||||||
shares withheld upon stock vesting | -4,050,000 | -9,385,000 | -4,490,000 | -2,688,000 | -5,421,000 | -2,832,000 | -1,305,000 | -6,454,000 | -5,726,000 | -758,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
supplemental disclosures of non-cash financing activities: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net increase in cash and cash equivalents | 528,000 | -9,675,000 | -72,353,000 | -60,459,000 | 33,642,000 | 35,917,000 | 28,967,000 | 18,137,000 | -18,587,000 | -17,534,000 | 49,019,000 | 25,169,000 | -11,761,000 | -6,078,000 | 29,081,000 | 15,573,000 | -6,714,000 | -90,833,000 | -92,163,000 | 28,573,000 | 93,552,000 | 81,542,000 | 47,495,000 | 42,313,000 | -54,530,000 | -30,954,000 | 7,120,000 | 23,262,000 | 28,481,000 | -2,952,000 | 70,902,000 | -7,494,559 | -5,441 | 19,715 | -2,737 | 4,460 | 3,480 | |||||||||||||||||||||||||||||||||
cash and cash equivalents at beginning of period | 20,229,000 | 20,229,000 | 20,229,000 | 86,363,000 | 86,363,000 | 86,363,000 | 30,197,000 | 30,197,000 | 30,197,000 | 27,502,000 | 27,502,000 | 27,502,000 | 8,032,000 | 8,032,000 | 8,032,000 | 17,303,000 | 17,303,000 | 17,303,000 | 14,545,000 | 14,545,000 | 14,545,000 | 48,004,000 | 48,004,000 | 48,004,000 | 120,295,000 | 120,295,000 | 120,295,000 | 34,485,000 | 34,485,000 | 34,485,000 | 2,847,000 | 2,847,000 | 56,190,000 | 56,190,000 | 56,190,000 | 84,221,000 | 84,221,000 | 84,221,000 | 17,231,000 | 17,231,000 | 17,231,000 | 0 | 0 | 89,679,000 | 0 | 29,749,221 | 29,779 | 0 | 0 | 4,861 | ||||||||||||||||||||
cash and cash equivalents at end of period | 20,757,000 | 13,902,000 | 10,554,000 | 14,010,000 | 25,904,000 | 120,005,000 | 66,114,000 | 59,164,000 | 48,334,000 | 8,915,000 | 9,968,000 | 7,824,000 | 57,051,000 | 33,201,000 | 3,132,000 | 5,542,000 | 11,225,000 | 2,840,000 | 43,626,000 | 30,118,000 | 7,021,000 | 39,106,000 | 37,158,000 | 41,290,000 | 29,462,000 | 28,132,000 | 148,868,000 | 128,037,000 | 116,027,000 | 81,980,000 | 45,160,000 | 898,000 | 5,664,000 | 1,660,000 | 25,236,000 | 66,592,000 | 91,341,000 | 107,483,000 | 9,855,000 | 7,957,000 | 9,476,000 | -51,313,000 | -6,854,000 | 78,917,000 | 70,902,000 | 22,254,662 | 24,338 | -2,737 | 4,460 | 8,341 | ||||||||||||||||||||
write off of deferred debt issuance costs | 38,000 | 2,513,000 | 488,000 | 406,000 | 406,000 | 406,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net decrease in cash and cash equivalents | -6,327,000 | -19,678,000 | -4,900,000 | -14,463,000 | -7,524,000 | -8,898,000 | -10,846,000 | -7,376,000 | -9,274,000 | -7,755,000 | -6,854,000 | -10,762,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
write-off of investment | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
tax benefit from stock options exercised and restricted stock vesting | 7,241,000 | 7,130,000 | 159,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
assets contributed to equity investment | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
capital leases | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of stock upon exercise of stock options and warrants | 2,749,000 | 2,609,000 | 125,000 | 4,214,000 | 4,203,000 | 653,000 | 399,000 | 195,000 | 181,000 | 89,000 | 258,000 | 113,000 | 145,000 | 145,000 | 245,000 | 236,000 | 96,000 | 1,494,000 | 1,358,000 | 939,000 | 966,000 | 454,000 | 2,757,000 | 2,505,000 | 1,071,000 | 458,000 | 1,183,000 | 1,742,000 | 796,000 | 306,000 | 1,385,000 | 1,650,181 | 819 | 184 | 60 | 453 | ||||||||||||||||||||||||||||||||||
securities class action lawsuit settlement accrual | 28,712,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
provision for doubtful accounts | 18,078,000 | 10,992,000 | 6,341,000 | 13,664,000 | 8,193,000 | 3,940,000 | 9,370,000 | 5,732,000 | 2,976,000 | 13,392,000 | 9,210,000 | 4,968,000 | 12,853,000 | 8,722,000 | 3,967,000 | 16,286,000 | 10,621,000 | 5,913,000 | 9,918,000 | 5,290,000 | 3,162,000 | 14,069,000 | 8,808,000 | 4,345,000 | 16,481,000 | 11,903,000 | 15,505,000 | 9,277,000 | 3,595,000 | 9,032,000 | ||||||||||||||||||||||||||||||||||||||||
gain on sale of care centers | -184,000 | -2,967,000 | -2,967,000 | -645,000 | -1,808,000 | -357,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
write off of deferred debt issuance costs/debt discount | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchases of deferred compensation plan assets | -19,000 | -19,000 | -19,000 | -104,000 | -67,000 | -33,000 | -93,000 | -74,000 | -29,000 | -155,000 | -127,000 | -47,000 | -472,000 | -379,000 | -219,000 | -1,053,000 | -1,018,000 | -54,000 | -3,064,000 | -2,969,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||
purchase of investments | -2,495,000 | -9,732,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from sale of investment | 5,000,000 | 5,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from disposition of care centers | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from revolving line of credit | 128,500,000 | 84,000,000 | 40,500,000 | 63,400,000 | 63,400,000 | 40,800,000 | 200,800,000 | 200,800,000 | 54,000,000 | 25,500,000 | 25,500,000 | 12,500,000 | 50,200,000 | 50,200,000 | 10,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||
repayments of revolving line of credit | -128,500,000 | -84,000,000 | -25,500,000 | -78,400,000 | -78,400,000 | -55,800,000 | -190,800,000 | -95,800,000 | -54,000,000 | -25,500,000 | -25,500,000 | -12,500,000 | -130,700,000 | -119,700,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of long-term obligations | 100,000,000 | 67,371,000 | 412,000,000 | 395,000,000 | 395,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
sale of non-controlling interest | 405,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
equity in loss from equity method investments | 106,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
u.s. department of justice settlement | 150,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
supplemental disclosures of non-cash financing and investing activities: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(sale) acquisition of non-controlling interests | -1,549,000 | -1,549,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from dispositions of care centers | 413,000 | 645,000 | 3,725,000 | 2,082,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
equity in earnings of equity investments | -8,701,000 | -6,777,000 | -1,951,000 | -2,234,000 | -1,671,000 | -787,000 | -1,054,000 | -700,000 | -363,000 | -1,091,000 | -701,000 | -305,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
u.s. department of justice settlement accrual | -115,000,000 | -115,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from deferred compensation plan assets | 1,077,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net loss | -23,959,000 | -34,832,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
adjustments to reconcile net loss to net cash from operating activities: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
tax benefit from stock option exercises | 5,000 | -3,038,000 | -2,917,000 | -944,000 | -427,000 | -334,000 | -82,000 | 2,427,000 | 2,192,000 | 714,000 | 847,000 | 637,000 | 2,764,000 | 1,645,000 | 285,000 | 1,134,000 | 764,000 | 251,000 | 324,000 | 1,955,000 | 688,000 | 341,000 | 198,000 | 1,185,000 | 1,049,120 | 880 | 417 | 0 | 0 | 9 | ||||||||||||||||||||||||||||||||||||||||
goodwill and other intangibles impairment charge | 574,114,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchases of investments | -3,421,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
notes payable issued for software licenses | 2,214,000 | 10,801,000 | 10,801,000 | 2,126,000 | 1,946,000 | 5,501,000 | 5,501,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other intangibles impairment charge | 2,208,000 | 2,208,000 | 2,208,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from dispositions of care centers, net of cash sold | 4,233,000 | 2,233,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
acquired non-controlling interests | 312,000 | 167,000 | 167,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
payment of deferred financing fees | -8,124,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
notes payable issued for/assumed in acquisitions | 1,058,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
write off of intangible assets | 3,828,000 | 2,286,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
acquisitions of reacquired franchise rights | -2,376,000 | -2,377,000 | -2,377,000 | -5,214,000 | -5,214,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
equity in earnings from equity investments | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
outstanding checks in excess of bank balance | -3,422,000 | -3,379,000 | 4,542,000 | 1,657,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
equity in earnings of unconsolidated joint ventures | -1,114,000 | -789,000 | -323,000 | -2,310,000 | -1,522,000 | -788,000 | -1,721,000 | -1,066,000 | -557,000 | -387,000 | -150,000 | 43,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
notes payable issued for acquisitions | 750,000 | 750,000 | 500,000 | 8,455,000 | 3,834,000 | 6,688,000 | 3,499,000 | 1,545,000 | 15,892,000 | 6,010,000 | 1,900,000 | 2,520,000 | 2,520,000 | 1,350,000 | 500,000 | 2,900,000 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
gain on release of alliance’s net liabilities | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
obligations due medicare | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchases of short-term investments | -89,000,000 | -53,000,000 | -34,200,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from sales of short-term investments | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
withdrawals from restricted cash | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net (decrease) in cash and cash equivalents | -1,949,000 | -50,526,000 | -17,629,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
benefit from doubtful accounts | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net cash (used in) investing activities | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from swingline facility | 21,700,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
repayments of swingline facility | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
minority interests | -43,000 | -25,000 | -27,000 | -10,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
impairment of intangible assets | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
release of shares from escrow | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
deposits into restricted cash | -1,136,000 | -1,116,000 | -1,124,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchase of deferred compensation plan assets | -1,761,000 | -1,659,000 | -67,000 | -1,955,000 | -1,873,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from equity offering | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
issuance cost related to equity offering | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from short-term revolving line of credit | 10,000,000 | 10,000,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
principal payments of short-term revolving line of credit | -10,000,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
repayments from swingline facility | -21,700,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash paid for 2005 payroll taxes under hurricane relief act extended deadlines | 26,906,000 | 26,906,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
non-cash compensation expense | 4,244,000 | 2,321,000 | 1,053,000 | 2,359,000 | 1,531,000 | 731,000 | 1,990,000 | 1,193,000 | 596,000 | 128,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
401(k) employer match expense | 8,726,000 | 5,357,000 | 2,714,000 | 4,627,000 | 2,361,000 | 493,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from sales and maturities of short-term investments | 89,000,000 | 53,000,000 | 34,200,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
sale of deferred compensation plan assets | 600,000 | 600,000 | 698,000 | 697,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
changes in assets and liabilities, net of impact of acquisitions: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(increase) in patient accounts receivable | -30,416,000 | -19,442,000 | -5,329,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
decrease in other current assets | -484,000 | -523,000 | 4,189,000 | 5,790,000 | 6,280,000 | 926,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
decrease in other assets | -219,000 | 76,000 | 1,458,000 | 1,124,000 | 226,000 | 756,000 | 962,000 | -1,028,530 | -470 | 11 | 20 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(decrease) in accounts payable | -8,237,000 | -638,000 | -1,215,000 | -4,126,000 | -3,362,000 | -17,055,000 | -22,001,000 | -719 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
increase in accrued expenses | 24,633,000 | 10,382,000 | 22,811,000 | 15,363,000 | 10,690,000 | 12,334,000 | 8,789,000 | 5,662,000 | -10,168,000 | 7,951,000 | 5,124,000 | 7,913,000 | 1,311,000 | -1,214,000 | 6,985,386 | 1,614 | -3 | 1,340 | 1,240 | 848 | ||||||||||||||||||||||||||||||||||||||||||||||||||
increase in other long-term obligations | 1,227,000 | 16,000 | 260,000 | 238,000 | 472,000 | 358,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(decrease) in obligations due medicare | -216,000 | -211,000 | -211,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
issuance costs related to issuance of long-term debt | -8,124,000 | -7,939,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
decrease in patient accounts receivable | -13,689,000 | 4,599,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
write-off of deferred debt issuance costs | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
write-off of medical supplies | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
changes in assets and liabilities, net of impact of acquisitions | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
increase in accounts payable | -17,290,000 | 19,752,000 | -2,262,000 | 3,007,000 | 1,670 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
sale of short-term investments | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of long-term obligations, net of issuance cost | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
stock issued for acquisitions | 0 | 1,500,000 | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
alliance | -4,212,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
provision for bad debts | 5,376,000 | 2,552,000 | 7,747,000 | 4,004,000 | 2,009,000 | 1,144,000 | 2,175,000 | 1,126,000 | 648,000 | 527,000 | 909,000 | 1,618,257 | 743 | 658 | 583 | 504 | 494 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
(decrease) in other long-term obligations | -58,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(increase) in other current assets | -3,226,000 | -244,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(decrease) in medicare liabilities | -3,244,000 | -1,509,000 | -6,000 | -902 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
acquisitions of businesses | -10,312,000 | -8,767,000 | -4,091,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents at beginning of year | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash and cash equivalents at end of year | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
supplemental disclosures of non cash financing and investing activities: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
stock issued for 401(k) plan | 5,199,000 | 3,199,000 | 1,471,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
amortization of deferred debt issue costs | 362,000 | 242,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
write off of inventory | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
changes in assets and liabilities, net of acquisitions: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(increase) in accounts receivable | -21,102,000 | -63,000 | -1,272,000 | -10,036,000 | -13,272,000 | -1,018,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds for sales and maturities of short–term investments | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
changes in assets and liabilities: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(increase) in other assets | -891,000 | 1,753,000 | -1,243,000 | -2,363,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
other increases | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash paid for payroll taxes under hurricane relief act extended deadlines | 26,906,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
compensation expense due to issuance of stock and stock options | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
loss on disposals of property and equipment | -22,000 | -16,000 | 15,000 | 38,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
increase in patient accounts receivable | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
increase in inventory and other current assets | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
increase in other assets | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
increase in amounts due to medicare | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
acquisition of businesses | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of long-term debt | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from equity offering, net of costs | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
principal payments of long-term debt | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
principal payments of revolving line of credit | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
payments on notes payable and capital leases | -648,000 | -820,000 | -1,144,000 | -3,260,227 | -1,773 | -1,780 | -1,658 | -1,772 | -1,700 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from private placement of stock | -23 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
decrease in medicare liabilities | 272 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash paid for income taxes | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
writeoff of inventory | 0 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(increase) in inventory and other current assets | 502,000 | -481,000 | -1,588,000 | -719 | -564 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
(decrease) in long-term liabilities | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
purchase of property and equipment | -3,747,000 | -6,173,000 | -5,518,000 | -1,661,000 | -1,686,000 | -1,883,375 | -625 | -1,044 | -122 | -325 | -298 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash from purchase acquisitions | -121,571,000 | -3,925,000 | -15,743,000 | -4,595,000 | -20,727,849 | -14,151 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of long-term debt, net of issuance cost | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
payments on long-term debt and capital leases | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from 2004 secondary equity offering, net of offering costs | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
supplemental disclosures of cash flow information | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
interest paid | 425,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income taxes paid, net of refunds received | 25,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
non-cash financing activities: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
stock issued as contributions to the company’s 401(k) plan | 1,043,000 | 943,000 | 729,000 | 528,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
stock issued to sellers in acquisitions | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
notes payable issued to sellers in acquisitions | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
capital leases entered into | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
decrease in accounts payable | 381 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of notes payable | 0 | 455,000 | 416,583 | 417 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
costs associated with equity offerings | 0 | -21,000 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
financing activities: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
compensation expense | 69,000 | 5,000 | 25,980 | 20 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
increase in medicare liabilities | -64,000 | 4 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of stock from employee stock purchase plan | 291,000 | 222,000 | 349,847 | 153 | 151 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash paid for: | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
interest | 68,000 | 87,000 | 72,000 | 193,891 | 109 | 254 | 276 | 296 | 340 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income taxes, net of refunds received | 1,546,000 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
supplemental disclosures of noncash financing and investing activities | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
changes in assets and liabilities, net of impact of acquisitions— | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
partnership distributions | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net (payments) on line of credit agreements | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
payments on notes payable | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
decrease in long-term liabilities | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from other issuance of stock | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from employee stock purchase plan | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
income taxes | 348,000 | 1,576,000 | 805,700 | 300 | 128 | 56 | 116 | -151 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
supplemental disclosures of non cash financing and investing activities | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
decrease in accounts receivable | 668,000 | -6,275,549 | -451 | -2,726 | 934 | 2,746 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
decrease in inventory and other current assets | -375,000 | 39 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
increase in long-term liabilities | -1 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
expenses incurred from 2003 private placement of stock | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
depreciation | 894 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
deferred revenue | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
gain on sale of discontinued operations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
minority interest | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
increase in cash included in assets held for sale | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from sale of discontinued operations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
minority interest investment in subsidiary | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net (payments) borrowings on line of credit agreements | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of notes payable and capital leases | 91 | 472 | 135 | 544 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
proceeds from issuance of stock | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
decrease in notes payable—related parties | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
increase in notes receivable—related parties | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net repayments on line of credit agreements | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
cash paid for | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
net (repayments) on line of credit agreements | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
impairment of goodwill | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
changes in assets and liabilities— | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
issuance of warrants for extinguishment of debt | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
decrease in notes payable — related parties | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
increase in notes receivable — related parties |